
<html lang="en"     class="pb-page"  data-request-id="80105466-b582-4e64-b115-e7d8237bfa77"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm200652u;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-18;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Kazutomo  Kinoshita" /></meta><meta name="dc.Creator" content="Takamitsu  Kobayashi" /></meta><meta name="dc.Creator" content="Kohsuke  Asoh" /></meta><meta name="dc.Creator" content="Noriyuki  Furuichi" /></meta><meta name="dc.Creator" content="Toshiya  Ito" /></meta><meta name="dc.Creator" content="Hatsuo  Kawada" /></meta><meta name="dc.Creator" content="Sousuke  Hara" /></meta><meta name="dc.Creator" content="Jun  Ohwada" /></meta><meta name="dc.Creator" content="Kazuo  Hattori" /></meta><meta name="dc.Creator" content="Takuho  Miyagi" /></meta><meta name="dc.Creator" content="Woo-Sang  Hong" /></meta><meta name="dc.Creator" content="Min-Jeong  Park" /></meta><meta name="dc.Creator" content="Kenji  Takanashi" /></meta><meta name="dc.Creator" content="Toshiyuki  Tsukaguchi" /></meta><meta name="dc.Creator" content="Hiroshi  Sakamoto" /></meta><meta name="dc.Creator" content="Takuo  Tsukuda" /></meta><meta name="dc.Creator" content="Nobuhiro  Oikawa" /></meta><meta name="dc.Description" content="9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design. The h..." /></meta><meta name="Description" content="9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design. The h..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 25, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200652u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200652u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200652u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200652u" /></link>
        
    
    

<title>9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200652u" /></meta><meta property="og:title" content="9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0009.jpeg" /></meta><meta property="og:description" content="9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design. The high target selectivity was achieved by introducing a substituent close to the E0 region of the ATP binding site, which has a unique amino acid sequence. Among the identified inhibitors, compound 13d showed highly selective and potent inhibitory activity against ALK with an IC50 value of 2.9 nM and strong antiproliferative activity against KARPAS-299 with an IC50 value of 12.8 nM. The compound also displayed significant antitumor efficacy in an established ALK fusion gene-positive anaplastic large-cell lymphoma (ALCL) xenograft model in mice without body weight loss." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200652u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200652u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200652u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200652u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200652u&amp;href=/doi/10.1021/jm200652u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 6286-6294</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200647u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200662c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kazutomo++Kinoshita">Kazutomo Kinoshita</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takamitsu++Kobayashi">Takamitsu Kobayashi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kohsuke++Asoh">Kohsuke Asoh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Noriyuki++Furuichi">Noriyuki Furuichi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toshiya++Ito">Toshiya Ito</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hatsuo++Kawada">Hatsuo Kawada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sousuke++Hara">Sousuke Hara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Ohwada">Jun Ohwada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kazuo++Hattori">Kazuo Hattori</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takuho++Miyagi">Takuho Miyagi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Woo-Sang++Hong">Woo-Sang Hong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Min-Jeong++Park">Min-Jeong Park</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenji++Takanashi">Kenji Takanashi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Toshiyuki++Tsukaguchi">Toshiyuki Tsukaguchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroshi++Sakamoto">Hiroshi Sakamoto</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takuo++Tsukuda">Takuo Tsukuda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nobuhiro++Oikawa">Nobuhiro Oikawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-text">C&C Research Laboratories, 146-141, Annyeong-dong, Hwaseong-si, Gyeonggi-do 445-380, Republic of Korea</span></div><div class="corresp-info">Phone: +81(467)47-6050. Fax: +81(467)47-2248. E-mail: <a href="/cdn-cgi/l/email-protection#2d464443425e4544594c4657596d4e45584a4c44005d454c5f40034e4203475d"><span class="__cf_email__" data-cfemail="375c5e5958445f5e43565c4d4377545f4250565e1a475f56455a195458195d47">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200652u&amp;href=/doi/10.1021%2Fjm200652u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 6286–6294</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 8, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 May 2011</li><li><span class="item_label"><b>Published</b> online</span>25 August 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 September 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200652u" title="DOI URL">https://doi.org/10.1021/jm200652u</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6286%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKazutomo%2BKinoshita%252C%2BTakamitsu%2BKobayashi%252C%2BKohsuke%2BAsoh%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D54%26issueNum%3D18%26contentID%3Djm200652u%26title%3D9-Substituted%2B6%252C6-Dimethyl-11-oxo-6%252C11-dihydro-5H-benzo%255Bb%255Dcarbazoles%2Bas%2BHighly%2BSelective%2Band%2BPotent%2BAnaplastic%2BLymphoma%2BKinase%2BInhibitors%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6294%26publicationDate%3DSeptember%2B2011">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200652u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3511</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">53</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200652u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;9-Substituted 6,6-Dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as Highly Selective and Potent Anaplastic Lymphoma Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kazutomo&quot;,&quot;last_name&quot;:&quot;Kinoshita&quot;},{&quot;first_name&quot;:&quot;Takamitsu&quot;,&quot;last_name&quot;:&quot;Kobayashi&quot;},{&quot;first_name&quot;:&quot;Kohsuke&quot;,&quot;last_name&quot;:&quot;Asoh&quot;},{&quot;first_name&quot;:&quot;Noriyuki&quot;,&quot;last_name&quot;:&quot;Furuichi&quot;},{&quot;first_name&quot;:&quot;Toshiya&quot;,&quot;last_name&quot;:&quot;Ito&quot;},{&quot;first_name&quot;:&quot;Hatsuo&quot;,&quot;last_name&quot;:&quot;Kawada&quot;},{&quot;first_name&quot;:&quot;Sousuke&quot;,&quot;last_name&quot;:&quot;Hara&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Ohwada&quot;},{&quot;first_name&quot;:&quot;Kazuo&quot;,&quot;last_name&quot;:&quot;Hattori&quot;},{&quot;first_name&quot;:&quot;Takuho&quot;,&quot;last_name&quot;:&quot;Miyagi&quot;},{&quot;first_name&quot;:&quot;Woo-Sang&quot;,&quot;last_name&quot;:&quot;Hong&quot;},{&quot;first_name&quot;:&quot;Min-Jeong&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Kenji&quot;,&quot;last_name&quot;:&quot;Takanashi&quot;},{&quot;first_name&quot;:&quot;Toshiyuki&quot;,&quot;last_name&quot;:&quot;Tsukaguchi&quot;},{&quot;first_name&quot;:&quot;Hiroshi&quot;,&quot;last_name&quot;:&quot;Sakamoto&quot;},{&quot;first_name&quot;:&quot;Takuo&quot;,&quot;last_name&quot;:&quot;Tsukuda&quot;},{&quot;first_name&quot;:&quot;Nobuhiro&quot;,&quot;last_name&quot;:&quot;Oikawa&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;6286-6294&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200652u&quot;},&quot;abstract&quot;:&quot;9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design. The high target selectivity was achieved by introducing a substituent close to the E0 region of the ATP binding site, which has a unique amino acid sequence. Among the identified inhibitors, compound 13d showed highly selective and potent inhibitory activity against ALK with an IC50 value of 2.9 nM and strong antiproliferative activity against KARPAS-299 with an IC50 value of 12.8 nM. The compound also displayed significant antitumor efficacy in an established ALK fusion gene-positive anaplastic large-cell lymphoma (ALCL) xenograft model in mice without body weight loss.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200652u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200652u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200652u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200652u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200652u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200652u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200652u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200652u&amp;href=/doi/10.1021/jm200652u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200652u" /></input><a href="/doi/pdf/10.1021/jm200652u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200652u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200652u%26sid%3Dliteratum%253Aachs%26pmid%3D21823617%26genre%3Darticle%26aulast%3DKinoshita%26date%3D2011%26atitle%3D9-Substituted%2B6%252C6-Dimethyl-11-oxo-6%252C11-dihydro-5H-benzo%255Bb%255Dcarbazoles%2Bas%2BHighly%2BSelective%2Band%2BPotent%2BAnaplastic%2BLymphoma%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D18%26spage%3D6286%26epage%3D6294%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jmcmar.2011.54.issue-18/production/jmcmar.2011.54.issue-18.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">9-Substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles were discovered as highly selective and potent anaplastic lymphoma kinase (ALK) inhibitors by structure-based drug design. The high target selectivity was achieved by introducing a substituent close to the E<sub>0</sub> region of the ATP binding site, which has a unique amino acid sequence. Among the identified inhibitors, compound <b>13d</b> showed highly selective and potent inhibitory activity against ALK with an IC<sub>50</sub> value of 2.9 nM and strong antiproliferative activity against KARPAS-299 with an IC<sub>50</sub> value of 12.8 nM. The compound also displayed significant antitumor efficacy in an established ALK fusion gene-positive anaplastic large-cell lymphoma (ALCL) xenograft model in mice without body weight loss.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) belonging to the insulin receptor superfamily, which includes insulin-like growth factor-1 receptor (IGF-1R) and leukocyte tyrosine kinase (LTK). The function of ALK in the normal human body is unclear. A possible role of ALK is in physiological development, and its expression in normal tissues is very restricted to the central nervous system.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The kinase was originally identified as a part of the fusion oncogene nucleophosmin (<i>NPM</i>)-<i>ALK</i> resulting from a t(2;5) chromosomal translocation in anaplastic large cell lymphomas (ALCL).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a><i>NPM</i>-<i>ALK</i> is detected in approximately 75% of all ALK-positive ALCL and is implicated in the pathogenesis of ALCL.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Not only <i>NPM</i>-<i>ALK</i> but also other ALK fusion genes have been identified in ALCL,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> inflammatory myofibroblastic tumor (IMT),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> diffuse large B-cell lymphoma (DLBCL),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> squamous cell carcinoma (SCC),<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and nonsmall cell lung cancer (NSCLC).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> It is noteworthy that echinoderm microtubule-associated protein-like 4(<i>EML4</i>)-<i>ALK</i> in NSCLC was the first fusion gene found to be an oncogenic factor in solid tumors.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a><i>EML4</i>-<i>ALK</i> has been detected in approximately 5% of NSCLC patients<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and is mutually exclusive for known oncogenic mutated-EGFR and KRAS.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition, genetic amplification and overexpression of ALK have recently been discovered to cause childhood neuroblastoma.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> These findings indicate that ALK is an attractive drug target for treatment of various ALK-positive cancers in blood and solid tumors.</div><div class="NLM_p">The inhibition of particular kinases is considered to have risk of adverse events. For example, inhibitions of KIT and KDR have been elucidated as associated with bone marrow suppression<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and hypertension,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> respectively. The most developed (as of this writing) ALK inhibitor <b>1</b> (crizotinib, Pfizer, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which has been tested clinically for treatment of EML4-ALK-positive NSCLC, is a MET/ALK dual inhibitor.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> On the other hand, our reported ALK inhibitor <b>2</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (IC<sub>50</sub> = 1.5 nM, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) did not have potent inhibitory activity against MET (IC<sub>50</sub> = 7200 nM) but showed submicromolar IC<sub>50</sub> values against several tyrosine kinases including KDR. Therefore, further modification was performed to address this issue.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of ALK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To achieve high target selectivity, on the basis of the binding mode of <b>2</b> with ALK homology models, we designed 9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles which recognize a unique amino acid sequence of ALK in the ATP binding site. For an efficient derivatization at the 9-position of 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole, we modified <b>13a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) as a scaffold instead of <b>2</b>, using a common intermediate. Eventually we identified the 9-ethyl derivative <b>13d</b> as a highly selective ALK inhibitor.</div><div class="NLM_p last">Herein, we wish to report the discovery of a highly selective and potent ALK inhibitor, <b>13d</b>, as well as its pharmacokinetics and in vivo efficacy.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31644" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31644" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The preparation of compound <b>13a</b> from intermediate <b>3</b><a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Aromatic nucleophilic substitution of <b>3</b> with <i>N</i>-Boc-piperazine gave compound <b>4</b>. After removal of Boc group with trifluoroacetic acid, reductive alkylation of <b>5</b> with 3-oxetanone and sodium triacetoxyborohydride in tetrahydrofuran afforded the target compound <b>13a</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>13a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-piperazine, NMP, 140 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 3-oxetanone, NaBH(OAc)<sub>3</sub>, THF, 40 °C.</p></p></figure><div class="NLM_p">The synthesis of 8,9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles (<b>13b</b>–<b>j</b>) is summarized in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. After bromination of compound <b>6</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> with <i>N</i>-bromosuccinimide, the Fischer indole ring formation of <b>7</b> gave a 1:1 mixture of regio isomers (1-CN- and 3-CN-derivatives). The undesired regio isomer (1-CN-derivative) was precipitated more easily than the desired one (3-CN-derivative) in organic solvents. Therefore, most of the undesired indole was removed by filtration. After washing with AcOEt/<i>n</i>-hexane, DDQ oxidation was conducted without further purification. Washing the resulting extract with AcOEt afforded the desired ketone <b>8</b> as a single product. A methoxy group at 8-position was converted into a triflate group by demethylation with pyridinium hydrochloride at 190 °C followed by treatment with triflic anhydride. The triflate <b>10</b> was treated with piperazine in NMP to give 8-piperazinyl compound <b>11</b>. The reductive alkylation of <b>11</b> with 3-oxetanone and sodium cyanoborohydride in tetrahydrofuran/methanol afforded <b>12</b>. A versatile intermediate <b>12</b> allows efficient derivatization at the 9-position. The intermediate was treated with corresponding building blocks under conventional Pd-catalyzed cross-coupling conditions to give compounds <b>13b</b>, <b>13h</b>, <b>13i</b>, and <b>13j</b>. 9-TIPS-acetylene derivative was deprotected with TBAF to give compound <b>13c</b>. Hydrogenation of <b>13c</b>, <b>13h</b>, <b>13i</b>, and <b>13j</b> with catalytic palladium on charcoal afforded the corresponding 9-alkyl derivatives <b>13d</b>, <b>13e</b>, <b>13f</b>, and <b>13g</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>13b</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-bromosuccinimide, CH<sub>3</sub>CN, rt; (b) 3-cyanophenylhydrazine, TFA, 100 °C; (c) DDQ, THF/H<sub>2</sub>O, 0 °C; (d) pyridinium hydrochloride, 190 °C; (e) trifluoromethanesulfonic anhydride, pyridine, rt; (f) piperazine, NMP, 120 °C; (g) 3-oxetanone, NaBH<sub>3</sub>CN, AcOH, THF/MeOH, rt; (h) trimethylboroxine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (i) TIPS-acetylene, Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, and then TBAF, THF, rt; (j) propyne, Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C; (k) isopropenylboronic acid pinacol ester, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 80 °C; (l) cyclopentylacetylene, Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C; (m) 10% Pd/C, H<sub>2</sub> gas, THF/MeOH, rt.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Molecular Design</h3><div class="NLM_p">Since our previous study<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> revealed that the ALK inhibitors bearing a 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole scaffold were ATP competitive, we investigated the amino acid sequences surrounding the ATP-binding site of several kinases. We found that the amino acid residues of the E<sub>0</sub> region<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> of ALK (A<sub>1200</sub> and G<sub>1201</sub>) were characteristically small (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) and that only 14 out of 490 kinases have the same amino acid sequence in the region as that of ALK (existence ratio is less than 3%).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The region often serves as an entrance for ligand binding, and ALK is considered to have a wide-open surface for binding of a ligand. Therefore, we considered that the steric repulsion between a ligand and the amino acid residues of the E<sub>0</sub> region of off-target proteins should afford high ALK selectivity.</div><figure id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Amino Acid Sequences of ALK and Off-Target Proteins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The docking study of <b>2</b> with our ALK homology models indicates that the 9-position of 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole scaffold would be closest to A<sub>1200</sub> of the E<sub>0</sub> region of ALK protein. During this work, we used ALK homology models for the docking study because no ALK crystal structure was available at that time. On the basis of the binding model, we designed 9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazoles to know the influence on kinase selectivity. Because the residues of amino acids in the E<sub>0</sub> region of ALK are hydrophobic (A<sub>1200</sub> and G<sub>1201</sub>), we chose several substituents which are expected to make a hydrophobic interaction with these residues. However, the regioselective C–C bond formation of intermediate <b>10</b> at either 8- or 9-position was not successful under palladium-catalyzed cross-coupling conditions (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Therefore, the C–N bond was formed regioselectively at the 8-position (from <b>10</b> to <b>11</b>), and an efficient derivatization at the 9-position was conducted from the common intermediate <b>12</b>.</div><div class="NLM_p">Recently, we obtained an X-ray cocrystal structure of another 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole derivative <b>14</b> (CH5424802, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>)<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> with human ALK (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AOX">3AOX</a>). The binding model<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> of <b>13a</b> derived from the X-ray coordinates (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) overlapped well with that of <b>2</b> based on our ALK homology models. The result indicates that our docking study is highly reliable.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding model of <b>13a</b> in complex with human ALK derived from the X-ray cocrystal structure with <b>14</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AOX">3AOX</a>). Compound <b>13a</b> is shown as a stick model colored by element type (C in green, O in red, and N in blue). Overall structure of human ALK is shown as a cartoon diagram in pale blue. Residues L<sub>1198</sub> through G<sub>1202</sub> of human ALK are shown as a stick model colored by element type as the ligand except C in white and S in yellow. A hydrogen bond between the carbonyl oxygen of <b>13a</b> and the backbone amide of M<sub>1199</sub> (hinge) is depicted by a yellow dashed line. Hydrogen atoms and solvent molecules are not displayed for clarity. The distance between C9 and alfa carbon of A<sub>1200</sub> is 4.2 Å. The figure was prepared with PyMol (<a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure–Activity Relationship (SAR)</h3><div class="NLM_p">The inhibitory activity against the four kinases and against KARPAS-299 (an <i>NPM</i>-<i>ALK</i>-positive ALCL cell line),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and the in vitro metabolic stability are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. As expected, a substituent at 9-position affected inhibitory activity against both ALK and off-target proteins. The 9-methyl group did not remarkably affect inhibitory activity against any proteins (<b>13b</b>). In contrast, bigger substituents than the methyl group notably weakened inhibitory activity against off-target proteins (<b>13c</b>–<b>13g</b>). These results indicate that steric bulkiness is a critical factor for inhibitory activity against off-target proteins. Among <b>13c</b>–<b>13g</b>, inhibitory activity against ALK was inversely proportional to bulkiness of the 9-substituent. The results suggest that C2-unit (ethyl and ethynyl groups) is optimum to occupy the space of the E<sub>0</sub> region and would make a hydrophobic interaction with the amino acid residues there.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Inhibitory Activity and Metabolic Stability of 9-Substituted Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0005.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0006.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">The values are averages of 2 separate determinations. The values in each assay are provided in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">On metabolic stability, on the other hand, there was no impact made by a substituent at 9-position except for the most bulky derivative <b>13g</b>, which showed relatively higher in vitro clearance (CL) value in mouse liver microsome in the presence of NADPH.</div><div class="NLM_p last">Among the derivatives, <b>13d</b> showed both strong inhibitory activity against ALK and antiproliferative activity against KARPAS-299 with high target selectivity and favorable in vitro metabolic stability.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Kinase Selectivity Profile</h3><div class="NLM_p">Compound <b>13d</b> was further evaluated for inhibitory activity against 17 tyrosine and serine/threonine kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compound <b>13d</b> showed improved target selectivity compared to that of our first generation ALK inhibitor <b>2</b>. The amino acid sequences in the E<sub>0</sub> region of 17 kinases support our hypothesis. It is noteworthy that <b>13d</b> showed a relatively low IC<sub>50</sub> value against INSR and that the kinase has the same amino acid in a corresponding position to that of A<sub>1200</sub> in ALK. This fact indicates that A<sub>1200</sub> would be a key amino acid for kinase selectivity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Activity of <b>2</b> and <b>13d</b> against 17 Kinases, and Amino Acids in the E<sub>0</sub> Region<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0007.gif" alt="" id="_i12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">The experimental details for each kinase are available in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div><div></div></div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Pharmacokinetics</h3><div class="NLM_p">The pharmacokinetic properties of <b>13d</b> were evaluated in monkeys (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compound <b>13d</b> demonstrated favorable plasma clearance in monkeys, which is consistent with in vitro CL values in human and mouse liver microsomes in the presence of NADPH. In addition, <b>13d</b> showed moderate bioavailability and <i>T</i><sub>1/2</sub> value. A preliminary pharmacokinetic study was conducted in mice. The result is provided in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Profiles of <b>13d</b> in Monkeys (Male and Female)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">po</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">iv</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center" char=".">AUC (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>tot</sub> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>dss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. 1</td><td class="colsep0 rowsep0" align="char" char=".">21.6</td><td class="colsep0 rowsep0" align="char" char=".">2510</td><td class="colsep0 rowsep0" align="char" char=".">288</td><td class="colsep0 rowsep0" align="char" char=".">6.27</td><td class="colsep0 rowsep0" align="char" char=".">0.808</td><td class="colsep0 rowsep0" align="char" char=".">0.298</td><td class="colsep0 rowsep0" align="char" char=".">4.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">no. 2</td><td class="colsep0 rowsep0" align="char" char=".">34.7</td><td class="colsep0 rowsep0" align="char" char=".">4030</td><td class="colsep0 rowsep0" align="char" char=".">366</td><td class="colsep0 rowsep0" align="char" char=".">6.22</td><td class="colsep0 rowsep0" align="char" char=".">0.652</td><td class="colsep0 rowsep0" align="char" char=".">0.294</td><td class="colsep0 rowsep0" align="char" char=".">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mean</td><td class="colsep0 rowsep0" align="char" char=".">28.2</td><td class="colsep0 rowsep0" align="char" char=".">3270</td><td class="colsep0 rowsep0" align="char" char=".">327</td><td class="colsep0 rowsep0" align="char" char=".">6.25</td><td class="colsep0 rowsep0" align="char" char=".">0.730</td><td class="colsep0 rowsep0" align="char" char=".">0.296</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Dose: po and iv at 0.5 mg/kg (<i>n</i> = 2).</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Oral bioavailability.</p></div></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Efficacy in Tumor Xenograft Studies</h3><div class="NLM_p">Compound <b>13d</b> was also evaluated in an established NPM-ALK-positive ALCL xenograft model in mice (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Mice bearing KARPAS-299 were administered <b>13d</b> orally once daily for 11 days at 2, 6, and 20 mg/kg, their body weight and the volume of the tumor were measured twice a week, and the relative body weight was calculated. Compound <b>13d</b> showed strong antitumor efficacy dose-dependently. A significant tumor regression (TGI = 119%) was observed at the dose of 20 mg/kg without apparent body weight loss. This efficacy is greater than that of the first generation ALK inhibitor <b>2</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Growth inhibitory effect of <b>13d</b> on KARPAS-299 tumor growth in mouse xenograft model. SCID mice bearing KARPAS-299 were administered compound <b>13d</b> orally once daily for 11 d (days 8–18) at 2 mg/kg (tumor growth inhibition TGI = 49%), 6 mg/kg (TGI = 103%), and 20 mg/kg (TGI = 119%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53476" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53476" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">By modifying our previously reported ALK inhibitor <b>2</b> bearing a unique 6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole scaffold, we identified highly selective ALK inhibitors which eliminate the concerns of adverse events caused by off-target kinase modulation. Among them, highly selective and potent ALK inhibitor <b>13d</b>, bearing an ethyl group at the 9-position, was discovered. The location of the ethyl group around the E<sub>0</sub> region at the binding sites of kinases might have afforded high ALK selectivity over off-target kinases. Compound <b>13d</b> showed inhibitory activity against ALK with an IC<sub>50</sub> value of 2.9 nM and antiproliferative activity against KARPAS-299 with an IC<sub>50</sub> value of 12.8 nM. The pharmacokinetic properties of <b>13d</b> were favorable. Oral administration of <b>13d</b> at 20 mg/kg demonstrated significant tumor regression (TGI = 119%) without body weight loss in an established NPM-ALK-positive ALCL xenograft model in mice.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21544" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21544" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div class="NLM_p">All solvents and reagents were obtained commercially. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a VARIAN 400-MR or a JEOL JNM-EX270 spectrometer, and chemical shifts are expressed as δ units using tetramethylsilane as an internal standard. The spectral splitting patterns are described as follows: s, singlet; d, doublet; dd, double doublet; t, triplet; q, quartet; m, multiplet; and bs, broad singlet peak. Liquid chromatography/mass spectra (LCMS) were measured by a Waters LCMS system with a SunFire C18 (5 μm, 4.6 mm × 50 mm) column or a Wakosil-II 3C18 AR (3.0–3.7 μm, 4.6 mm × 30 mm) column (mobile phase, CH<sub>3</sub>CN/H<sub>2</sub>O with 0.05% TFA; flow rate, 2.0 mL/min). High resolution mass spectra (HRMS) were measured with a Thermo Fisher Scientific LTQ Orbitrap XL MS spectrometer using an ESI source coupled to a Waters HPLC system operating in reversed phase with an ACQUITY UPLC BEH C18 (1.7 μm, 2.1 mm × 50 mm) column. Flash column chromatography was performed with Biotage SNAP cartridges or SILICYCLE SiliaSep packed columns. Preparative HPLC was conducted with a SunFire Prep C18 OBD (5 μm, 30 mm × 50 mm) column (mobile phase, CH<sub>3</sub>CN/H<sub>2</sub>O with 0.05% TFA). All tested compounds are ≥95% except for <b>13e</b> (93%). The purity was determined by LCMS analysis.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 6,6-Dimethyl-8-(1-oxetan-3-yl-piperidin-4-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>2</b>)</h4><div class="NLM_p last">The synthetic procedure of <b>2</b> was described in a previous report.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> LCMS (ESI), >95% pure; <i>m</i>/<i>z</i>, 426 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.74 (1H, bs), 8.32 (1H, d, <i>J</i> = 8.4 Hz), 8.13 (1H, d, <i>J</i> = 7.9 Hz), 8.00 (1H, s), 7.74 (1H, s), 7.61 (1H, d, <i>J</i> = 7.9 Hz), 7.40 (1H, d, <i>J</i> = 8.4 Hz), 4.56 (2H, t, <i>J</i> = 6.4 Hz), 4.46 (2H, t, <i>J</i> = 6.1 Hz), 3.46–3.39 (1H, m), 2.85–2.82 (2H, m), 2.71–2.64 (1H, m), 1.92–1.86 (2H, m), 1.82–1.79 (4H, m), 1.77 (6H, s). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 179.0, 160.1, 150.9, 148.1, 135.6, 129.3, 127.5, 125.7, 125.3, 125.0, 124.7, 121.5, 119.9, 116.3, 109.2, 104.5, 74.6, 58.5, 49.8, 41.9, 36.5, 32.2, 29.7. HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>28</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 426.2176, found 426.2179.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 4-(3-Cyano-6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazol-8-yl)-piperazine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>4</b>)</h4><div class="NLM_p last">To a solution of <b>3</b><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (25 mg, 0.058 mmol) in NMP (1.25 mL) was added <i>N</i>-Boc-piperazine (302 mg, 28 equiv). After stirring for 27 h at 140 °C, the reaction mixture was purified by preparative HPLC to give <b>4</b> (15 mg, 55%). <sup>1</sup>H NMR (270 MHz, CDCl<sub>3</sub>) δ 8.52 (1H, d, <i>J</i> = 8.1 Hz), 8.32 (1H, d, <i>J</i> = 9.7 Hz), 7.72 (1H, s), 7.53 (1H, d, <i>J</i> = 8.1 Hz), 6.94–7.03 (2H, m), 3.59–3.67 (4H, m), 3.32–3.42 (4H, m), 1.50 (9H, s). MS (ESI) <i>m</i>/<i>z</i>: 471 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 6,6-Dimethyl-11-oxo-8-piperazin-1-yl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>5</b>)</h4><div class="NLM_p last">To a solution of <b>4</b> (15 mg, 0.032 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) was added trifluoroacetic acid (0.4 mL, excess amount). After stirring for 2 h at room temperature, the reaction mixture was evaporated under reduced pressure. The residue was purified by preparative HPLC to give <b>5</b> as a light-yellow powder (10 mg, 89%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.32 (1H, d, <i>J</i> = 8.5 Hz), 8.03 (1H, d, <i>J</i> = 9.1 Hz), 7.99 (1H, s), 7.59 (1H, dd, <i>J</i> = 8.2, 1.5 Hz), 7.20 (1H, d, <i>J</i> = 2.4 Hz), 7.04 (1H, dd, <i>J</i> = 8.8, 2.1 Hz), 3.30–3.32 (4H, m), 2.87–2.88 (4H, m), 1.77 (6H, s). MS (ESI) <i>m</i>/<i>z</i>: 371 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6,6-Dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13a</b>)</h4><div class="NLM_p last">To a solution of <b>5</b> (26 mg, 0.07 mmol) in THF (2.0 mL) were added 3-oxetanone (15 mg, 3 equiv) and sodium triacetoxyborohydride (59 mL, 4 equiv). After stirring for 7 h at 40 °C, the reaction mixture was cooled to room temperature and evaporated under reduced pressure. The residue was dissolved with AcOEt. After addition of water, stirring of the resulting solution for 0.5 h at 0 °C afforded a precipitate. The precipitate was filtered off and washed with AcOEt/water to give <b>13a</b> as a light-yellow solid (27 mg, 90%). LCMS (ESI), >95% pure; <i>m</i>/<i>z</i>, 427 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.29 (1H, dd, <i>J</i> = 8.2, 0.59 Hz), 8.02 (1H, d, <i>J</i> = 9.0 Hz), 7.97 (1H, d, <i>J</i> = 0.59 Hz), 7.56 (1H, dd, <i>J</i> = 8.0, 1.4 Hz), 7.22 (1H, d, <i>J</i> = 2.3 Hz), 7.04 (1H, dd, <i>J</i> = 8.8, 2.2 Hz), 4.56–4.59 (2H, m), 4.47–4.50 (2H, m), 3.43–3.48 (1H, m), 3.39–3.42 (4H, m), 2.40–2.42 (4H, m), 1.74 (6H, s).</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 6-Bromo-7-methoxy-1,1-dimethyl-3,4-dihydro-1<i>H</i>-naphthalen-2-one (<b>7</b>)</h4><div class="NLM_p last">To a solution of <b>6</b><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> (2.00 g, 9.79 mmol) in CH<sub>3</sub>CN (40 mL) was added <i>N</i>-bromosuccinimide (1.92 g, 1.1 equiv). After stirring for 2.5 h at room temperature, the reaction mixture was poured into water (40 mL) to give a white precipitate. This was collected by filtration and air-dried to give <b>7</b> (2.55 g, 92%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 7.43 (1H, s), 7.04 (1H, s), 3.87 (3H, s), 2.98 (2H, t, <i>J</i> = 6.8 Hz), 2.59 (2H, t, <i>J</i> = 6.8 Hz), 1.34 (6H, s). HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>13</sub>H<sub>16</sub>O<sub>2</sub>Br [M + H]<sup>+</sup> 283.0328, found 283.0333.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 9-Bromo-8-methoxy-6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>8</b>)</h4><div class="NLM_p last">A mixture of <b>7</b> (7.89 g, 27.8 mmol), 3-cyanophenylhydrazine (4.45 g, 1.2 equiv), and trifluoroacetic acid (250 mL) was heated at 100 °C for 2 h. The reaction mixture was cooled and then evaporated under reduced pressure. The residue was neutralized by saturated aqueous NaHCO<sub>3</sub> and extracted with AcOEt. The combined organic layers were washed with brine, and precipitated solid (undesired regioisomer) was filtered off. The filtrate was evaporated under reduced pressure. The resulting solid was washed with AcOEt/<i>n</i>-hexane to give the desired compound roughly purified, which was used in the next reaction without further purification. To a solution of the compound in THF (120 mL) and water (12 mL) was gradually added DDQ (4.55 g, excess amount). After stirring for 3 h at 0 °C, the reaction mixture was evaporated under reduced pressure. The residue was dissolved with CPME. The solution was washed with aqueous NaOH, water, and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was washed with AcOEt to yield <b>8</b> (1.90 g, 17% in two steps from <b>7</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.82 (1H, s), 8.28–8.32 (2H, m), 8.03 (1H, s), 7.61 (1H, d, <i>J</i> = 8.4 Hz), 7.49 (1H, s), 4.04 (3H, s), 1.81 (6H, s). HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>16</sub>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 395.039, found 395.0392.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 9-Bromo-8-hydroxy-6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>9</b>)</h4><div class="NLM_p last">A mixture of <b>8</b> (270 mg, 0.68 mmol) and pyridinium hydrochloride (1.62 g, 22 equiv) was heated to 190 °C in the microwave for 1.5 h. The reaction mixture was dissolved in water, neutralized by saturated aqueous NaHCO<sub>3</sub>, and extracted with AcOEt/THF (×3). The combined organic layer was washed with aqueous NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography (<i>n</i>-hexane/AcOEt) to yield <b>9</b> as a brown solid (140 mg, 54%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.77 (1H, s), 11.13 (1H, s), 8.31 (1H, d, <i>J</i> = 7.9 Hz), 8.25 (1H, s), 8.01 (1H, s), 7.61 (1H, d, <i>J</i> = 7.9 Hz), 7.28 (1H, s), 1.74 (6H, s). HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>14</sub>BrN<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 381.0233, found 381.0239.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Trifluoromethanesulfonic Acid 9-Bromo-3-cyano-6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazol-8-yl Ester (<b>10</b>)</h4><div class="NLM_p last">To a solution of <b>9</b> (140 mg, 0.37 mmol) in pyridine (2 mL) was added trifluoromethanesulfonic anhydride (188 μL, 3 equiv) at 0 °C. After stirring for 1.5 h at room temperature, the reaction mixture was poured into aqueous NH<sub>4</sub>Cl and then extracted with AcOEt (× 2). The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography (<i>n</i>-hexane/AcOEt) to yield <b>10</b> as an off-white solid (120 mg, 64%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.99 (1H, s), 8.51 (1H, s), 8.31 (1H, d, <i>J</i> = 8.2 Hz), 8.17 (1H, s), 8.07 (1H, s), 7.67 (1 H, d, <i>J</i> = 8.2 Hz), 1.81 (6H, s). HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>13</sub>BrF<sub>3</sub>N<sub>2</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 512.9726, found 512.9728.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 9-Bromo-6,6-dimethyl-11-oxo-8-piperazin-1-yl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>11</b>)</h4><div class="NLM_p last">To a solution of <b>10</b> (6.0 g, 11.7 mmol) in NMP (75 mL) was added piperazine (10.1 g, 10 equiv). After stirring for 30 min at 120 °C, the reaction mixture was cooled and poured into water to afford precipitation. The precipitate was filtered off and dried under reduced pressure to yield <b>11</b> as a white solid (3.9 g, 74%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (1H, d, <i>J</i> = 7.9 Hz), 8.28 (1H, s), 8.00 (1H, s), 7.61 (1H, d, <i>J</i> = 7.9 Hz), 7.41 (1H, s), 3.32 (2H, bs), 3.01–3.10 (4H, m), 2.85–2.91 (4H, m), 1.76 (6H, s). HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>22</sub>BrN<sub>4</sub>O [M + H]<sup>+</sup> 449.0972, found 449.0973.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 9-Bromo-8-(4-cyclopropyl-piperazin-1-yl)-6,6-dimethyl-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>12</b>)</h4><div class="NLM_p last">To a solution of <b>11</b> (50 mg, 0.11 mmol) in MeOH/THF/AcOH (1.5 mL/1.5 mL/0.25 mL) were added 3-oxetanone (39.4 μL, 7 equiv) and sodium cyanoborohydride (36.8 mg, 5 equiv). To the mixture, an excess amount of 3-oxetanone (total 25 equiv) was added gradually at room temperature. The reaction was monitored by HPLC until the starting material was consumed (stirred for 24 h). The resulting reaction mixture was poured into water to give a precipitate. The precipitated solid was filtered off and washed with water to afford <b>12</b> as an off-white solid (41.2 mg, 73%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.83 (1H, s), 8.30 (1H, d, <i>J</i> = 7.9 Hz), 8.28 (1H, s), 8.02 (1H, s), 7.62 (1H, d, <i>J</i> = 7.9 Hz), 7.48 (1H, s), 4.56–4.61 (2H, m), 4.46–4.51 (2H, m), 3.47–3.56 (1H, m), 3.15–3.24 (4H, m), 2.44–2.54 (4H, m), 1.78 (6H, s). HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>26</sub>BrN<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 505.1234, found 505.1235.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6,6,9-Trimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13b</b>)</h4><div class="NLM_p last">A mixture of <b>12</b> (30 mg, 0.06 mmol), trimethylboroxine (16.5 μL, 2 equiv), potassium carbonate (24.6 mg, 3 equiv), DMF (0.9 mL), and Pd(PPh<sub>3</sub>)<sub>4</sub> (6.86 mg, 0.1 equiv) was stirred for 10 h at 100 °C. The reaction mixture was then cooled, diluted with AcOEt, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by preparative HPLC to give <b>13b</b> (11.2 mg, 42%). LCMS (ESI), >95% pure; <i>m</i>/<i>z</i>, 441 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (270 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.71 (1H, s), 8.32 (1H, d, <i>J</i> = 8.1 Hz), 8.01 (1H, s), 7.97 (1H, s), 7.60 (1H, d, <i>J</i> = 8.1 Hz), 7.32 (1H, s), 4.57–4.61 (2H, m), 4.47–4.51 (2H, m), 3.49–3.55 (1H, m), 2.99–3.11 (4H, m), 2.42–2.50 (4H, m), 2.33 (3H, s), 1.76 (6H, s).</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 9-Ethynyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13c</b>)</h4><div class="NLM_p last">A mixture of <b>12</b> (26.7 mg, 0.05 mmol), TIPS-acetylene (17.8 μL, 1.5 equiv), cesium carbonate (81.5 mg, 4.5 equiv), X-Phos (7.56 mg, 0.3 equiv), CH<sub>3</sub>CN (1.0 mL), and Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub> (1.37 mg, 0.1 equiv) was stirred for 4 h at 80 °C. The reaction mixture was then cooled, diluted with AcOEt, washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was used in the next reaction without further purification. To a solution of the residue in THF (2.0 mL) was added TBAF (74.2 μL, 1.5 equiv). After stirring for 1 h at room temperature, the reaction mixture was diluted with AcOEt, washed with water (× 6) and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was triturated with MeOH (1.0 mL). The precipitated solid was filtered off and washed with <i>n</i>-hexane to afford <b>13c</b> as a brown solid (10.7 mg, 48%). LCMS (ESI), 95% pure; <i>m</i>/<i>z</i> 451 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 12.77 (1H, s), 8.31 (1H, d, <i>J</i> = 7.9 Hz), 8.16 (1H, s), 8.02 (1H, s), 7.61 (1H, d, J = 7.9 Hz), 7.27 (1H, s), 4.55–4.63 (2H, m), 4.46–4.53 (3H, m), 3.47–3.56 (1H, m), 3.35–3.43 (4H, m), 2.43–2.50 (4H, m), 1.78 (6H, s). HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 451.2129, found 451.2127.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 9-Ethyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13d</b>)</h4><div class="NLM_p last">To a solution of <b>13c</b> (34.0 mg, 0.08 mmol) in MeOH/THF (1.6 mL/2.4 mL), 10% palladium on charcoal (20 mg, 60% w/w) was added at room temperature. After being stirred vigorously under hydrogen gas for 2 h at room temperature, the reaction mixture was filtered through Celite. The filtrate was concentrated under reduced pressure. The residue was purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH) to yield <b>13d</b> as a white solid (6.9 mg, 19%). LCMS (ESI), 95% pure; <i>m</i>/<i>z</i> 455 [M + H]<sup>+</sup>.; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.70 (1H, s), 8.29 (1H, d, <i>J</i> = 8.4 Hz), 8.05 (1H, s), 8.00 (1H, s), 7.61 (1H, d, <i>J</i> = 8.4 Hz), 7.38 (1H, s), 4.55–4.62 (2H, m), 4.45–4.52 (2H, m), 3.48–3.55 (1H, m), 2.98–3.05 (4H, m), 2.71 (2H, q, <i>J</i> = 7.5 Hz), 2.43–2.51 (4H, m), 1.74 (6H, s), 1.26 (3H, t, <i>J</i> = 7.5 Hz). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 179.1, 159.9, 155.0, 146.8, 136.5, 135.8, 127.8, 126.4, 126.0, 124.5, 121.6, 119.9, 116.7, 116.2, 109.5, 104.7, 74.3, 58.6, 51.5, 49.4, 36.6, 30.1, 22.7, 14.5. HRMS (ESI), <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 455.2442, found 455.2440.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6,6-Dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-9-prop-1-ynyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13h</b>)</h4><div class="NLM_p last">A mixture of <b>12</b> (210 mg, 0.42 mmol), cesium carbonate (609 mg, 4.5 equiv), X-Phos (29.7 mg, 0.15 equiv), CH<sub>3</sub>CN (8.0 mL), and Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub> (5.39 mg, 0.05 equiv) was stirred under propyne gas for 16 h at 80 °C. The reaction mixture was cooled and then triturated with water (12 mL). The precipitated solid was filtered off and washed with AcOEt/<i>n</i>-hexane to yield <b>13h</b> as a brown solid (153 mg, 79%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.37 (1H, d, <i>J</i> = 8.2 Hz), 8.18 (1H, s), 7.84 (1H, s), 7.53 (1H, d, <i>J</i> = 8.2 Hz), 7.19 (1H, s), 4.70–4.77 (2H, m), 4.62–4.68 (2H, m), 3.57–3.63 (1H, m), 3.38–3.45 (4H, m), 2.54–2.61 (4H, m), 2.10 (3H, s), 1.79 (6H, s). MS (ESI) <i>m</i>/<i>z</i>: 465 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6,6-Dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-9-propyl-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13e</b>)</h4><div class="NLM_p last">Compound <b>13e</b> was prepared from <b>13h</b> following the same procedure as described for <b>13d</b> (48%, an off-white solid). LCMS (ESI), 93% pure; <i>m</i>/<i>z</i> 469 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (270 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.75 (1H, s), 8.30 (1H, d, <i>J</i> = 8.2 Hz), 7.97–8.01 (2H, m), 7.59 (1H, d, <i>J</i> = 8.2 Hz), 7.38 (1H, s), 4.53–4.61 (2H, m), 4.43–4.51 (2H, m), 3.49–3.55 (1H, m), 2.96–3.02 (4H, m), 2.63 (2H, t, <i>J</i> = 7.3 Hz), 2.41–2.47 (4H, m), 1.73 (6H, s), 1.61–1.70 (2H, m), 0.94 (3H, t, <i>J</i> = 7.4 Hz).</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 9-Isopropenyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13i</b>)</h4><div class="NLM_p last">A mixture of <b>12</b> (56 mg, 0.11 mmol), isopropenylboronic acid pinacol ester (29.3 μL, 1.4 equiv), sodium carbonate (35.2 mg, 3 equiv), DME/water (2.5 mL/0.5 mL), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (3.88 mg, 0.05 equiv) was stirred for 38 h at 80 °C. The reaction mixture was cooled and then triturated with water (9.0 mL). The precipitated solid was filtered off and purified by flash column chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH) to yield <b>13i</b> as a white solid (19.0 mg, 37%). <sup>1</sup>H NMR (270 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 8.44 (1H, d, <i>J</i> = 7.8 Hz), 8.09 (1H, s), 7.83 (1H, s), 7.54 (1H, d, <i>J</i> = 7.8 Hz), 7.18 (1H, s), 5.20–5.24 (2H, m), 4.68–4.81 (4H, m), 3.56–3.70 (1H, m), 3.24–3.34 (4H, m), 2.52–2.61 (4H, m), 2.21 (3H, s), 1.82 (6H, s). MS (ESI) <i>m</i>/<i>z</i>: 467 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 9-Isopropyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13f</b>)</h4><div class="NLM_p last">Compound <b>13f</b> was prepared from <b>13i</b> following the same procedure as described for <b>13d</b> (38%, a white solid). LCMS (ESI), >95% pure; <i>m</i>/<i>z</i> 469 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (270 MHz, CD<sub>3</sub>OD + CDCl<sub>3</sub>) δ 8.44 (1H, d, <i>J</i> = 7.8 Hz), 8.27 (1H, s), 7.84 (1H, s), 7.54 (1H, d, <i>J</i> = 7.8 Hz), 7.36 (1H, s), 4.70–4.82 (4H, m), 3.63–3.73 (1H, m), 3.35–3.52 (1H, m), 3.09–3.13 (4H, m), 2.55–2.72 (4H, m), 1.81 (6H, s), 1.31 (6H, d, <i>J</i> = 7.0 Hz).</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 9-Cyclopentylethynyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13j</b>)</h4><div class="NLM_p last">A mixture of <b>12</b> (38 mg, 0.08 mmol), cyclopentylacetylene (26 μL, 3 equiv), cesium carbonate (97.9 mg, 4 equiv), X-Phos (5.37 mg, 0.15 equiv), CH<sub>3</sub>CN (2.0 mL), and Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub> (0.97 mg, 0.05 equiv) was stirred for 14 h at 80 °C. The reaction mixture was cooled and then triturated with water (2.0 mL). The precipitated solid was filtered off and washed with <i>n</i>-hexane to yield <b>13j</b> as a light-brown solid (25 mg, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.74 (1H, s), 8.31 (1H, d, <i>J</i> = 8.4 Hz), 8.04 (1H, s), 8.00 (1H, s), 7.60 (1H, d, <i>J</i> = 8.4 Hz), 7.22 (1H, s), 4.54–4.63 (2H, m), 4.43–4.53 (2H, m), 3.45–3.53 (1H, m), 3.34–3.43 (4H, m), 2.89–2.98 (1H, m), 2.41–2.50 (4H, m), 1.92–2.05 (2H, m), 1.76 (6H, s), 1.51–1.81 (6H, m). MS (ESI) <i>m</i>/<i>z</i>: 519 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 9-(2-Cyclopentyl-ethyl)-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5<i>H</i>-benzo[<i>b</i>]carbazole-3-carbonitrile (<b>13g</b>)</h4><div class="NLM_p last">Compound <b>13g</b> was prepared from <b>13j</b> following the same procedure as described for <b>13d</b> (29%, a white solid). LCMS (ESI), >95% pure; <i>m</i>/<i>z</i> 523 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (270 MHz, CD<sub>3</sub>OD) δ 8.40 (1H, d, <i>J</i> = 7.8 Hz), 8.13 (1H, s), 7.86 (1H, s), 7.55 (1H, d, <i>J</i> = 7.8 Hz), 7.40 (1H, s), 4.62–4.78 (4H, m), 3.52–3.68 (1H, m), 3.07–3.11 (4H, m), 2.72–2.78 (2H, m), 2.56–2.60 (4H,m), 1.80 (6H, s), 1.20–1.90 (11H, m).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> In Vitro Kinase Enzyme Assay</h3><div class="NLM_p last">ALK protein was purchased from Carna Biosciences. The inhibitory ability was evaluated by examining their ability to phosphorylate substrate peptide (Biotin-EGPWLEEEEEAYGWMDF) in the presence of 30 μM ATP and 10 mM MgCl<sub>2</sub> using time-resolved fluorescence resonance energy transfer (TR-FRET) assay. The inhibitory activity against Raf-1 was evaluated by examining the ability of the kinase to phosphorylate MEK1/2 using europium-antiphospho-MEK1/2 (Ser217/221) antibody. The quantity of enzyme and ATP and the kind of substrate and cation species added in each assay for evaluation of other kinases are given in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> In Vitro Cell Growth Assay</h3><div class="NLM_p last">KARPAS-299 cells were treated with various concentrations of assay compounds for 96 h. Cell growth inhibition was determined by Cell Counting Kit-8 assay.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> In Vivo Antitumor Activity on KARPAS-299 in SCID Mice</h3><div class="NLM_p last">Cell line (KARPAS-299) was used to evaluate antitumor activity of <b>13d</b> in vivo. It was grown as sc tumors in SCID mice (CLEA Japan, Inc.). Therapeutic experiments were started (day 0) when the tumor reached around 200 mm<sup>3</sup>. Mice (four mice per group) were randomized to treatment groups to receive vehicle or <b>13d</b> (oral, QD) on days 0 to 10. Final concentration of vehicle was 10% DMSO, 10% Cremophor EL, 15% PEG400, and 15% HPCD (2-hydroxypropyl-β-cyclodextrin). Compound <b>13d</b> was given to mice by forced oral administration using a sonde tube. The length (<i>L</i>) and width (<i>W</i>) of the tumor mass were measured, and the tumor volume (TV) was calculated as: TV = (<i>L</i> × <i>W</i><sub>2</sub>)/2. Body weight change rate (BW) was calculated using the following formula: BW = <i>W</i>/<i>W</i><sub>0</sub> × 100, where <i>W</i> and <i>W</i><sub>0</sub> are the body weight on a specific experimental day and on the first day of treatment, respectively. Tumor growth inhibition (TGI) was calculated using the following formula: TGI = [1 – (<i>T</i> – <i>T</i><sub>0</sub>)/(<i>C</i> – <i>C</i><sub>0</sub>)] × 100, where <i>T</i> and <i>T</i><sub>0</sub> are the mean tumor volumes on a specific experimental day and on the first day of treatment, respectively, for the experimental groups and likewise, where <i>C</i> and <i>C</i><sub>0</sub> are the mean tumor volumes for the control group.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> In Vitro Metabolic Stability in Liver Microsomes</h3><div class="NLM_p last">Microsomal stability assay: 1 μM of each compound was incubated with human (or mouse) liver microsome (0.5 mg protein/mL) in 50 mM phosphate buffer (pH 7.4) containing 1 mM NADPH (the reduced form of nicotinamide adenine dinucleotide phosphate) at 37 °C for 30 min. After the enzyme reaction was terminated with the addition of a 3-fold volume of acetonitrile, the reaction mixture was centrifuged at 1500 rpm for 10 min. The resultant supernatant was used as a test sample to measure the stability in human (or mouse) liver microsome by quantitating the compound in the sample using LC/MS.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Determination of Pharmacokinetic Parameters in Monkeys</h3><div class="NLM_p last">Fasted cynomolgus monkeys (<i>n</i> = 2 per treatment group) were given <b>13d</b> by oral (po) or intravenous (iv) route at a dose of 0.5 mg/kg. Compound <b>13d</b> was dissolved in a vehicle of 20% EtOH, 10% Cremophor EL, 15% PEG400, 15% HPCD (2-hydroxypropyl-β-cyclodextrin), and 0.02 mol/L HCl in water. Blood samples were collected with heparin as an anticoagulant at 0.08, 0.25, 1, 2, 4, 7, 24, and 48 h following iv dosing and at 0.50, 1, 2, 4, 7, 24, and 48 h following oral dosing. Samples were centrifuged and the plasma collected and stored at −80 °C until analysis. Samples were analyzed by LC-MS/MS technique. The pharmacokinetic parameters were calculated by noncompartmental analysis.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/jm200652u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental conditions for enzyme assays. IC<sub>50</sub> values of Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> in each assay. Amino acid sequences of the 14 kinases having AG at the E<sub>0</sub> region. Pharmacokinetic study of <b>13d</b> in mice. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200652u/suppl_file/jm200652u_si_001.pdf">jm200652u_si_001.pdf (72.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200652u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazutomo Kinoshita</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3b505255544853524f5a50414f7b58534e5c5a52164b535a495615585415514b"><span class="__cf_email__" data-cfemail="91faf8fffee2f9f8e5f0faebe5d1f2f9e4f6f0f8bce1f9f0e3fcbff2febffbe1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takamitsu Kobayashi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kohsuke Asoh</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noriyuki Furuichi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toshiya Ito</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hatsuo Kawada</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sousuke Hara</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Ohwada</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kazuo Hattori</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takuho Miyagi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Woo-Sang Hong</span> - <span class="hlFld-Affiliation affiliation">C&C Research Laboratories, 146-141, Annyeong-dong, Hwaseong-si, Gyeonggi-do 445-380, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Min-Jeong Park</span> - <span class="hlFld-Affiliation affiliation">C&C Research Laboratories, 146-141, Annyeong-dong, Hwaseong-si, Gyeonggi-do 445-380, Republic of Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenji Takanashi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Toshiyuki Tsukaguchi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroshi Sakamoto</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takuo Tsukuda</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nobuhiro Oikawa</span> - <span class="hlFld-Affiliation affiliation">Research Division, Chugai Pharmaceutical Co., Ltd., 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Y. Tachibana, K. Sakata, and T. Fujii for biological assays, K. H. Ahn for chemical synthesis, S. Kuramoto and N. Shibahara for PK analysis, Y. Akada, M. Hiramoto and K. Yoshinari for physicochemical assays, and H. Suda, F. Matsuno and Y. Ishiguro for mass spectrometry measurements.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> Abbreviations Used</h2><tr><td class="NLM_term">ALCL</td><td class="NLM_def"><p class="first last">anaplastic large cell lymphomas</p></td></tr><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>t</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CPME</td><td class="NLM_def"><p class="first last">cyclopropyl methyl ether</p></td></tr><tr><td class="NLM_term">DDQ</td><td class="NLM_def"><p class="first last">2,3-dichloro-5,6-dicyanobenzoquinone</p></td></tr><tr><td class="NLM_term">DLBCL</td><td class="NLM_def"><p class="first last">diffuse large B-cell lymphoma</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EML4</td><td class="NLM_def"><p class="first last">echinoderm microtubule-associated protein-like 4</p></td></tr><tr><td class="NLM_term">IGF-1R</td><td class="NLM_def"><p class="first last">insulin-like growth factor-1 receptor</p></td></tr><tr><td class="NLM_term">IMT</td><td class="NLM_def"><p class="first last">inflammatory myofibroblastic tumor</p></td></tr><tr><td class="NLM_term">INSR</td><td class="NLM_def"><p class="first last">insulin receptor</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain receptor</p></td></tr><tr><td class="NLM_term">KRAS</td><td class="NLM_def"><p class="first last">v-<i>K</i><sub>i</sub>-ras2 Kirsten rat sarcoma viral oncogene homologue</p></td></tr><tr><td class="NLM_term">LTK</td><td class="NLM_def"><p class="first last">leukocyte tyrosine kinase</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl pyrrolidone</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">nonsmall cell lung cancer</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SCC</td><td class="NLM_def"><p class="first last">squamous cell carcinoma</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TIPS</td><td class="NLM_def"><p class="first last">triisopropylsilyl</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. P.</span><span> </span><span class="NLM_article-title"><i>ALK</i>, The Chromosome 2 Gene Locus Altered by the t(2;5) in Non-Hodgkin’s Lymphoma, Encodes a Novel Neural Receptor Tyrosine Kinase That Is Highly Related to Leukocyte Tyrosine Kinase (LTK)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2175-2188&author=S.+W.+Morrisauthor=C.+Naeveauthor=P.+Mathewauthor=P.+L.+Jamesauthor=M.+N.+Kirsteinauthor=X.+Cuiauthor=D.+P.+Witte&title=ALK%2C+The+Chromosome+2+Gene+Locus+Altered+by+the+t%282%3B5%29+in+Non-Hodgkin%E2%80%99s+Lymphoma%2C+Encodes+a+Novel+Neural+Receptor+Tyrosine+Kinase+That+Is+Highly+Related+to+Leukocyte+Tyrosine+Kinase+%28LTK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DNaeve%26aufirst%3DC.%26aulast%3DMathew%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DP.%2BL.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWitte%26aufirst%3DD.%2BP.%26atitle%3DALK%252C%2520The%2520Chromosome%25202%2520Gene%2520Locus%2520Altered%2520by%2520the%2520t%25282%253B5%2529%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%252C%2520Encodes%2520a%2520Novel%2520Neural%2520Receptor%2520Tyrosine%2520Kinase%2520That%2520Is%2520Highly%2520Related%2520to%2520Leukocyte%2520Tyrosine%2520Kinase%2520%2528LTK%2529%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D2175%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pulford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delsol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, D. Y.</span><span> </span><span class="NLM_article-title">Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells with the Monoclonal Antibody ALK1</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=1394-1404&author=K.+Pulfordauthor=L.+Lamantauthor=S.+W.+Morrisauthor=L.+H.+Butlerauthor=K.+M.+Woodauthor=D.+Stroudauthor=G.+Delsolauthor=D.+Y.+Mason&title=Detection+of+Anaplastic+Lymphoma+Kinase+%28ALK%29+and+Nucleolar+Protein+Nucleophosmin+%28NPM%29-ALK+Proteins+in+Normal+and+Neoplastic+Cells+with+the+Monoclonal+Antibody+ALK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPulford%26aufirst%3DK.%26aulast%3DLamant%26aufirst%3DL.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DButler%26aufirst%3DL.%2BH.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DStroud%26aufirst%3DD.%26aulast%3DDelsol%26aufirst%3DG.%26aulast%3DMason%26aufirst%3DD.%2BY.%26atitle%3DDetection%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%2520and%2520Nucleolar%2520Protein%2520Nucleophosmin%2520%2528NPM%2529-ALK%2520Proteins%2520in%2520Normal%2520and%2520Neoplastic%2520Cells%2520with%2520the%2520Monoclonal%2520Antibody%2520ALK1%26jtitle%3DBlood%26date%3D1997%26volume%3D89%26spage%3D1394%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin’s Lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+Kinase+Gene%2C+ALK%2C+to+a+Nucleolar+Protein+Gene%2C+NPM%2C+in+Non-Hodgkin%E2%80%99s+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520Kinase%2520Gene%252C%2520ALK%252C%2520to%2520a%2520Nucleolar%2520Protein%2520Gene%252C%2520NPM%252C%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span> </span><span class="NLM_article-title">Development of Anaplastic Lymphoma Kinase (ALK) Small-Molecule Inhibitors for Cancer Therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1002%2Fmed.20109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17694547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=372-412&author=R.+Liauthor=S.+W.+Morris&title=Development+of+Anaplastic+Lymphoma+Kinase+%28ALK%29+Small-Molecule+Inhibitors+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy</span></div><div class="casAuthors">Li, Rongshi; Morris, Stephan W.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-412</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fusion forms-the most common being nucleophosmin (NPM)-ALK-in a nonHodgkin's lymphoma (NHL) known as anaplastic large-cell lymphoma (ALCL) and subsequent studies identified ALK fusions in the human sarcomas called inflammatory myofibroblastic tumors (IMTs).  In addn., two recent reports have suggested that the ALK fusion, TPM4-ALK, may be involved in the genesis of a subset of esophageal squamous cell carcinomas.  While the cause-effect relationship between ALK fusions and malignancies such as ALCL and IMT is very well established, more circumstantial links implicate the involvement of the full-length, normal ALK receptor in the genesis of addnl. malignancies including glioblastoma, neuroblastoma, breast cancer, and others; in these instances, ALK is believed to foster tumorigenesis following activation by autocrine and/or paracrine growth loops involving the reported ALK ligands, pleiotrophin (PTN) and midkine (MK).  There are no currently available ALK small-mol. inhibitors approved for clin. cancer therapy; however, recognition of the variety of malignancies in which ALK may play a causative role has recently begun to prompt developmental efforts in this area.  This review provides a succinct summary of normal ALK biol., the confirmed and putative roles of ALK fusions and the full-length ALK receptor in the development of human cancers, and efforts to target ALK using small-mol. kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB3B7c_OpT2LVg90H21EOLACvtfcHk0lj2DOg2QDhttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyltLs%253D&md5=d8521d00232b6b3d1c807fb65645ac67</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.20109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20109%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26atitle%3DDevelopment%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%2520Small-Molecule%2520Inhibitors%2520for%2520Cancer%2520Therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D372%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slavish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentrop, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span> </span><span class="NLM_article-title">Anaplastic Lymphoma Kinase: Role in Cancer Pathogenesis and Small-Molecule Inhibitor Development for Therapy</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1586%2F14737140.9.3.331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19275511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=331-356&author=T.+R.+Webbauthor=J.+Slavishauthor=R.+E.+Georgeauthor=A.+T.+Lookauthor=L.+Xueauthor=Q.+Jiangauthor=X.+Cuiauthor=W.+B.+Rentropauthor=S.+W.+Morris&title=Anaplastic+Lymphoma+Kinase%3A+Role+in+Cancer+Pathogenesis+and+Small-Molecule+Inhibitor+Development+for+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy</span></div><div class="casAuthors">Webb, Thomas R.; Slavish, Jake; George, Rani E.; Look, A. Thomas; Xue, Liquan; Jiang, Qin; Cui, Xiaoli; Rentrop, Walter B.; Morris, Stephan W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-356</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase in the insulin receptor superfamily, was initially identified in constitutively activated oncogenic fusion forms - the most common being nucleophosmin-ALK - in anaplastic large-cell lymphomas, and subsequent studies have identified ALK fusions in diffuse large B-cell lymphomas, systemic histiocytosis, inflammatory myofibroblastic tumors, esophageal squamous cell carcinomas and non-small-cell lung carcinomas.  More recently, genomic DNA amplification and protein overexpression, as well as activating point mutations, of ALK have been described in neuroblastomas.  In addn. to those cancers for which a causative role for aberrant ALK activity is well validated, more circumstantial links implicate the full-length, normal ALK receptor in the genesis of other malignancies - including glioblastoma and breast cancer - via a mechanism of receptor activation involving autocrine and/or paracrine growth loops with the reported ALK ligands, pleiotrophin and midkine.  This review summarizes normal ALK biol., the confirmed and putative roles of ALK in the development of human cancers and efforts to target ALK using small-mol. kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERzbvlik_c7Vg90H21EOLACvtfcHk0lj2DOg2QDhttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D&md5=a980ef18ac316bd3894b72ddd2748c17</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1586%2F14737140.9.3.331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.9.3.331%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DSlavish%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DRentrop%26aufirst%3DW.%2BB.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26atitle%3DAnaplastic%2520Lymphoma%2520Kinase%253A%2520Role%2520in%2520Cancer%2520Pathogenesis%2520and%2520Small-Molecule%2520Inhibitor%2520Development%2520for%2520Therapy%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D331%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Griffin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlman, E. J.</span><span> </span><span class="NLM_article-title">Recurrent Involvement of 2p23 in Inflammatory Myofibroblastic Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2776</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=10383129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2776-2780&author=C.+A.+Griffinauthor=A.+L.+Hawkinsauthor=C.+Dvorakauthor=C.+Henkleauthor=T.+Ellinghamauthor=E.+J.+Perlman&title=Recurrent+Involvement+of+2p23+in+Inflammatory+Myofibroblastic+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span></div><div class="casAuthors">Griffin, Constance A.; Hawkins, Anita L.; Dvorak, Cecily; Henkle, Carol; Ellingham, Tara; Perlman, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2776-2780</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Inflammatory myofibroblastic tumor (IMT) is a relatively rare soft tissue tumor.  The reactive vs. neoplastic pathogenesis of this tumor is unresolved.  We found clonal chromosome aberrations involving 2p23 upon metaphase anal. of two IMTs.  Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated rearrangement of the probe in both of these cases and in a third case, and immunohistochem. revealed ALK expression in all three cases.  A 2p22-24 involvement has been reported previously in four addnl. cases of IMT.  We suggest that chromosomal rearrangements involving 2p23 near or within ALK are recurrent alterations in IMT and that ALK may have a novel role outside its previously recognized realm of lymphoid neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocvXV2ukz3crVg90H21EOLACvtfcHk0lj2DOg2QDhttg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D&md5=8054eeaaf0cb85ee85afff461797c84c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DHawkins%26aufirst%3DA.%2BL.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DHenkle%26aufirst%3DC.%26aulast%3DEllingham%26aufirst%3DT.%26aulast%3DPerlman%26aufirst%3DE.%2BJ.%26atitle%3DRecurrent%2520Involvement%2520of%25202p23%2520in%2520Inflammatory%2520Myofibroblastic%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2776%26epage%3D2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Subero, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestou, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Hermelink, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auvigne, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delsol, G.</span><span> </span><span class="NLM_article-title">ALK-Positive Diffuse Large B-cell Lymphoma is Associated with <i>Clathrin-ALK</i> Rearrangements: Report of 6 Cases</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2568</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1182%2Fblood-2003-03-0786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=12763927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=2568-2573&author=R.+D.+Gascoyneauthor=L.+Lamantauthor=J.+I.+Martin-Suberoauthor=V.+S.+Lestouauthor=N.+L.+Harrisauthor=H.+K.+Muller-Hermelinkauthor=J.+F.+Seymourauthor=L.+J.+Campbellauthor=D.+E.+Horsmanauthor=I.+Auvigneauthor=E.+Espinosauthor=R.+Siebertauthor=G.+Delsol&title=ALK-Positive+Diffuse+Large+B-cell+Lymphoma+is+Associated+with+Clathrin-ALK+Rearrangements%3A+Report+of+6+Cases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ALK-positive diffuse large B-cell lymphoma is associated with clathrin-ALK rearrangements: Report of 6 cases</span></div><div class="casAuthors">Gascoyne, Randy D.; Lamant, Laurence; Martin-Subero, Jose I.; Lestou, Valia S.; Harris, Nancy Lee; Mueller-Hermelink, Hans-Konrad; Seymour, John F.; Campbell, Lynda J.; Horsman, Douglas E.; Auvigne, Isabelle; Espinos, Estelle; Siebert, Reiner; Delsol, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2568-2573</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Expression of ALK protein by lymphoid cells and the description of variant anaplastic lymphoma kinase (ALK) translocations have typically been restricted to cases of T-cell and null anaplastic large-cell lymphoma (ALCL).  All such cases result from a novel fusion created by the ALK gene on chromosome 2p23 and NPM on 5q35 or other variant translocation partners.  A rare variant of diffuse large B-cell lymphoma (DLBCL), originally described in 1997, was thought to overexpress full-length ALK in contrast to a chimeric protein characteristic of ALCL.  However, full-length ALK protein lacks tyrosine kinase activity and thus the mechanism of oncogenesis has remained elusive.  We describe 6 cases of ALK+ DLBCL characterized by a simple or complex t(2;17)(p23;q23) involving the clathrin gene (CLTC) at chromosome band 17q23 and the ALK gene at chromosome band 2p23.  All cases were studied using fluorescence in situ hybridization (FISH), complemented in one case with std. cytogenetic anal., multicolor karyotyping (M-FISH), and reverse transcriptase-polymerase chain reaction.  These results clearly demonstrate that most cases of ALK+ DLBCL share the same mechanism of deregulated ALK expression.  Moreover, these results demonstrate the presence of CLTC-ALK fusions in these tumors and extend the list of diseases assocd. with this genetic abnormality to include classical T-cell or null ALCL, ALK+ DLBCL, and inflammatory myofibroblastic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3UcmsuahiXLVg90H21EOLACvtfcHk0lhS2rGAM5W76w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslykurw%253D&md5=9eedc8c22c580dbadee982b4d3da35a8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-03-0786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-03-0786%26sid%3Dliteratum%253Aachs%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DLamant%26aufirst%3DL.%26aulast%3DMartin-Subero%26aufirst%3DJ.%2BI.%26aulast%3DLestou%26aufirst%3DV.%2BS.%26aulast%3DHarris%26aufirst%3DN.%2BL.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DCampbell%26aufirst%3DL.%2BJ.%26aulast%3DHorsman%26aufirst%3DD.%2BE.%26aulast%3DAuvigne%26aufirst%3DI.%26aulast%3DEspinos%26aufirst%3DE.%26aulast%3DSiebert%26aufirst%3DR.%26aulast%3DDelsol%26aufirst%3DG.%26atitle%3DALK-Positive%2520Diffuse%2520Large%2520B-cell%2520Lymphoma%2520is%2520Associated%2520with%2520Clathrin-ALK%2520Rearrangements%253A%2520Report%2520of%25206%2520Cases%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D2568%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jazii, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najafi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrads, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziaee, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abnet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazdznbod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karkhane, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salekdeh, G. H.</span><span> </span><span class="NLM_article-title">Identification of Squamous Cell Carcinoma Associated Proteins by Proteomics and Loss of Beta Tropomyosin Expression in Esophageal Cancer</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">7104</span><span class="NLM_x">–</span> <span class="NLM_lpage">7112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.3748%2Fwjg.v12.i44.7104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17131471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1GksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=7104-7112&author=F.+R.+Jaziiauthor=Z.+Najafiauthor=R.+Malekzadehauthor=T.+P.+Conradsauthor=A.+A.+Ziaeeauthor=C.+Abnetauthor=M.+Yazdznbodauthor=A.+A.+Karkhaneauthor=G.+H.+Salekdeh&title=Identification+of+Squamous+Cell+Carcinoma+Associated+Proteins+by+Proteomics+and+Loss+of+Beta+Tropomyosin+Expression+in+Esophageal+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer</span></div><div class="casAuthors">Jazii, Ferdous Rastgar; Najafi, Zahra; Malekzadeh, Reza; Conrads, Thomas P.; Ziaee, Abed Ali; Abnet, Christian; Yazdznbod, Mansour; Karkhane, Ali Asghar; Salekdeh, Ghasem H.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">7104-7112</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">To assess the proteome of normal vs. tumor tissue in squamous cell carcinoma of the esophagus (SCCE) in Iranian patients and compare our results with former reports by using proteomics.  Protein was extd. from normal and tumor tissues.  Two dimensional electrophoresis was carried out and spots with differential expression were identified with mass spectrometry.  RNA extn. and RT-PCR along with immunodetection were performed.  Fourteen proteins were found whose expression levels differed in tumor compared to normal tissues.  Mass spectrometric anal. resulted in the identification of β-tropomyosin (TMβ), myosin light chain 2 (and its isoform), myosin regulatory light chain 2, peroxyredoxin 2, annexin I and an unknown polypeptide as the down regulated polypeptides in tumor tissue.  Heat shock protein 70 (HSP70), TPM4-ALK fusion oncoprotein 2, myosin light polypeptide 6, keratin I, GH16431p and calreticulin were the up-regulated polypeptides found in tumor tissue.  Several of these proteins, such as TMβ, HSP70, annexin I, calreticulin, TPM4-ALK and isoforms of myosins, have been well recognized in tumorigenesis of esophageal or other types of cancers.  The study not only supports the involvement of some of the formerly reported proteins in SCCE but also introduces addnl. proteins found to be lost in SCCE, including TMβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQBiL27ZRH7Vg90H21EOLACvtfcHk0lhS2rGAM5W76w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1GksA%253D%253D&md5=2de4e4dc1639b4414afa8ea6e072c22c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v12.i44.7104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v12.i44.7104%26sid%3Dliteratum%253Aachs%26aulast%3DJazii%26aufirst%3DF.%2BR.%26aulast%3DNajafi%26aufirst%3DZ.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DConrads%26aufirst%3DT.%2BP.%26aulast%3DZiaee%26aufirst%3DA.%2BA.%26aulast%3DAbnet%26aufirst%3DC.%26aulast%3DYazdznbod%26aufirst%3DM.%26aulast%3DKarkhane%26aufirst%3DA.%2BA.%26aulast%3DSalekdeh%26aufirst%3DG.%2BH.%26atitle%3DIdentification%2520of%2520Squamous%2520Cell%2520Carcinoma%2520Associated%2520Proteins%2520by%2520Proteomics%2520and%2520Loss%2520of%2520Beta%2520Tropomyosin%2520Expression%2520in%2520Esophageal%2520Cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2006%26volume%3D12%26spage%3D7104%26epage%3D7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the Transforming <i>EML4-ALK</i> Fusion Gene in Non-small-cell Lung Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1038%2Fnature05945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17625570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+Transforming+EML4-ALK+Fusion+Gene+in+Non-small-cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span></div><div class="casAuthors">Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7153</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improvement in the clin. outcome of lung cancer is likely to be achieved by identification of the mol. events that underlie its pathogenesis.  Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-assocd. protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.  Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and s.c. tumors in nude mice.  The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examd.; these individuals were distinct from those harboring mutations in the epidermal growth factor receptor gene.  Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic mol. marker in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhAXuLtrJ6rVg90H21EOLACvtfcHk0lgsbYnR2NpqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D&md5=7f567e80814b9ccc87e5bceeebb467a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature05945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05945%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520Transforming%2520EML4-ALK%2520Fusion%2520Gene%2520in%2520Non-small-cell%2520Lung%2520Cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Non-solid Oncogenes in Solid Tumors: <i>EML4-ALK</i> Fusion Genes in Lung Cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2349</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1111%2Fj.1349-7006.2008.00972.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19032370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=2349-2355&author=H.+Mano&title=Non-solid+Oncogenes+in+Solid+Tumors%3A+EML4-ALK+Fusion+Genes+in+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span></div><div class="casAuthors">Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2349-2355</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that recurrent chromosome translocations play a major role in the mol. pathogenesis of hematol. malignancies but not of solid tumors.  However, chromosome translocations involving the e26 transformation-specific sequence transcription factor loci have been demonstrated recently in many prostate cancer cases.  Furthermore, through a functional screening with retroviral cDNA expression libraries, we have discovered the fusion-type protein tyrosine kinase echinoderm microtubule-assocd. protein like-4 (EML4)-anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) specimens.  A recurrent chromosome translocation, inv(2)(p21p23), in NSCLC generates fused mRNA encoding the amino-terminal half of EML4 ligated to the intracellular region of the receptor-type protein tyrosine kinase ALK.  EML4-ALK oligomerizes constitutively in cells through the coiled coil domain within the EML4 region, and becomes activated to exert a marked oncogenicity both in vitro and in vivo.  Break and fusion points within the EML4 locus may diverge in NSCLC cells to generate various isoforms of EML4-ALK, which may constitute -5% of NSCLC cases, at least in the Asian ethnic group.  In the present review I summarize how detection of EML4-ALK cDNA may become a sensitive diagnostic means for NSCLC cases that are pos. for the fusion gene, and discuss whether suppression of ALK enzymic activity could be an effective treatment strategy against this intractable disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxSS7U51wKbVg90H21EOLACvtfcHk0lgsbYnR2NpqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D&md5=84386550daedbd29b3a34b11a4774684</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00972.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00972.x%26sid%3Dliteratum%253Aachs%26aulast%3DMano%26aufirst%3DH.%26atitle%3DNon-solid%2520Oncogenes%2520in%2520Solid%2520Tumors%253A%2520EML4-ALK%2520Fusion%2520Genes%2520in%2520Lung%2520Cancer%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D2349%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Koivunen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span> </span><span class="NLM_article-title"><i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4275</span><span class="NLM_x">–</span> <span class="NLM_lpage">4283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1158%2F1078-0432.CCR-08-0168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=18594010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4275-4283&author=J.+P.+Koivunenauthor=C.+Mermelauthor=K.+Zejnullahuauthor=C.+Murphyauthor=E.+Lifshitsauthor=A.+J.+Holmesauthor=H.+G.+Choiauthor=J.+Kimauthor=D.+Chiangauthor=R.+Thomasauthor=J.+Leeauthor=W.+G.+Richardsauthor=D.+J.+Sugarbakerauthor=C.+Duckoauthor=N.+Lindemanauthor=J.+P.+Marcouxauthor=J.+A.+Engelmanauthor=N.+S.+Grayauthor=C.+Leeauthor=M.+Meyersonauthor=P.+A.+J%C3%A4nne&title=EML4-ALK+Fusion+Gene+and+Efficacy+of+an+ALK+Kinase+Inhibitor+in+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer</span></div><div class="casAuthors">Koivunen, Jussi P.; Mermel, Craig; Zejnullahu, Kreshnik; Murphy, Carly; Lifshits, Eugene; Holmes, Alison J.; Choi, Hwan Geun; Kim, Jhingook; Chiang, Derek; Thomas, Roman; Lee, Jinseon; Richards, William G.; Sugarbaker, David J.; Ducko, Christopher; Lindeman, Neal; Marcoux, J. Paul; Engelman, Jeffrey A.; Gray, Nathanael S.; Lee, Charles; Meyerson, Matthew; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4275-4283</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The EML4-ALK fusion gene has been detected in ∼7% of Japanese non-small cell lung cancers (NSCLC).  We detd. the frequency of EML4-ALK in Caucasian NSCLC and in NSCLC cell lines.  We also detd. whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK-contg. cell lines in vitro and in vivo.  We screened 305 primary NSCLC [both U.S. (n = 138) and Korean (n = 167) patients] and 83 NSCLC cell lines using reverse transcription-PCR and by exon array analyses.  We evaluated the efficacy of TAE684 against NSCLC cell lines in vitro and in vivo.  We detected four different variants, including two novel variants, of EML4-ALK using reverse transcription-PCR in 8 of 305 tumors (3%) and 3 of 83 (3.6%) NSCLC cell lines.  All EML4-ALK-contg. tumors and cell lines were adenocarcinomas.  EML4-ALK was detected more frequently in NSCLC patients who were never or light (<10 pack-years) cigarette smokers compared with current/former smokers (6% vs. 1%; P = 0.049).  TAE684 inhibited the growth of one of three (H3122) EML4-ALK-contg. cell lines in vitro and in vivo, inhibited Akt phosphorylation, and caused apoptosis.  In another EML4-ALK cell line, DFCI032, TAE684 was ineffective due to coactivation of epidermal growth factor receptor and ERBB2.  The combination of TAE684 and CL-387,785 (epidermal growth factor receptor/ERBB2 kinase inhibitor) inhibited growth and Akt phosphorylation and led to apoptosis in the DFCI032 cell line.  EML4-ALK is found in the minority of NSCLC.  ALK kinase inhibitors alone or in combination may nevertheless be clin. effective treatments for NSCLC patients whose tumors contain EML4-ALK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOXKywqERg6rVg90H21EOLACvtfcHk0lgsbYnR2NpqSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D&md5=6e29703c783e6a29cf77e3c4b93fc15f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0168%26sid%3Dliteratum%253Aachs%26aulast%3DKoivunen%26aufirst%3DJ.%2BP.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DDucko%26aufirst%3DC.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DMarcoux%26aufirst%3DJ.%2BP.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DEML4-ALK%2520Fusion%2520Gene%2520and%2520Efficacy%2520of%2520an%2520ALK%2520Kinase%2520Inhibitor%2520in%2520Lung%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D4275%26epage%3D4283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Inamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mun, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span> </span><span class="NLM_article-title"><i>EML4-ALK</i> Lung Cancers Are Characterized by Rare Other Mutations, A TTF-1 Cell Lineage, An Acinar Histology, and Young Onset</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1038%2Fmodpathol.2009.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19234440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslyqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=508-515&author=K.+Inamuraauthor=K.+Takeuchiauthor=Y.+Togashiauthor=S.+Hatanoauthor=H.+Ninomiyaauthor=N.+Motoiauthor=M.+Y.+Munauthor=Y.+Sakaoauthor=S.+Okumuraauthor=K.+Nakagawaauthor=M.+Sodaauthor=Y.+L.+Choiauthor=H.+Manoauthor=Y.+Ishikawa&title=EML4-ALK+Lung+Cancers+Are+Characterized+by+Rare+Other+Mutations%2C+A+TTF-1+Cell+Lineage%2C+An+Acinar+Histology%2C+and+Young+Onset"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset</span></div><div class="casAuthors">Inamura, Kentaro; Takeuchi, Kengo; Togashi, Yuki; Hatano, Satoko; Ninomiya, Hironori; Motoi, Noriko; Mun, Ming-yon; Sakao, Yukinori; Okumura, Sakae; Nakagawa, Ken; Soda, Manabu; Choi, Young Lim; Mano, Hiroyuki; Ishikawa, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Modern Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">508-515</span>CODEN:
                <span class="NLM_cas:coden">MODPEO</span>;
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A subset of lung cancers harbors a small inversion within chromosome 2p, giving rise to a transforming fusion gene, EML4-ALK (echinoderm microtubule-assocd. protein-like 4 gene and the anaplastic lymphoma kinase gene), which encodes an activated tyrosine kinase.  We have earlier examd. the presence of EML4-ALK by multiplex reverse transcription-polymerase chain reaction in 363 specimens of lung cancer, identifying 11 adenocarcinoma cases featuring the fusion gene.  In this study, we clinicopathol. examd. the characteristics of the EML4-ALK-pos. cases, including the mutation status of EGFR, KRAS, and TP53, and whether they were of thyroid transcription factor-1 (TTF-1) cell lineage or not.  Of 11 patients, 4 (36%) with EML4-ALK-pos. lung adenocarcinomas who were below 50 years of age were affected by these diseases, as compared with 12 of 242 patients (5.0%) with EML4-ALK-neg. lung adenocarcinomas (P=0.00038).  EML4-ALK-pos. lung adenocarcinomas were characterized by less-differentiated grade (P=0.0082) and acinar-predominant structure (P<0.0001) in histol.  Furthermore, the presence of EML4-ALK appears to be mutually exclusive for EGFR and KRAS mutations (P=0.00018), whereas coexisting with TP53 mutations at a low frequency (1/11=9.1%), and correlating with non- or light smoking (P=0.040), in line with the TTF-1 immunoreactivity.  Thus, EML4-ALK-pos. tumors may form a distinct entity among lung adenocarcinomas, characterized by young onset, acinar histol., no or rare mutations in EGFR, KRAS, and TP53, and a TTF-1 cell lineage, all in agreement with the prevalence in non- or light smokers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWmwK64d_PbVg90H21EOLACvtfcHk0liUG6m0QKxRKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslyqtLc%253D&md5=8ed0f0aa75ad9716fe4ae7c0b13754eb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fmodpathol.2009.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmodpathol.2009.2%26sid%3Dliteratum%253Aachs%26aulast%3DInamura%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DTogashi%26aufirst%3DY.%26aulast%3DHatano%26aufirst%3DS.%26aulast%3DNinomiya%26aufirst%3DH.%26aulast%3DMotoi%26aufirst%3DN.%26aulast%3DMun%26aufirst%3DM.%2BY.%26aulast%3DSakao%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DS.%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DMano%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DY.%26atitle%3DEML4-ALK%2520Lung%2520Cancers%2520Are%2520Characterized%2520by%2520Rare%2520Other%2520Mutations%252C%2520A%2520TTF-1%2520Cell%2520Lineage%252C%2520An%2520Acinar%2520Histology%252C%2520and%2520Young%2520Onset%26jtitle%3DMod.%2520Pathol.%26date%3D2009%26volume%3D22%26spage%3D508%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Osajima-Hakomori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, R.</span><span> </span><span class="NLM_article-title">Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1016%2FS0002-9440%2810%2962966-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=15972965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2005&pages=213-222&author=Y.+Osajima-Hakomoriauthor=I.+Miyakeauthor=M.+Ohiraauthor=A.+Nakagawaraauthor=A.+Nakagawaauthor=R.+Sakai&title=Biological+Role+of+Anaplastic+Lymphoma+Kinase+in+Neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Biological role of anaplastic lymphoma kinase in neuroblastoma</span></div><div class="casAuthors">Osajima-Hakomori, Yuko; Miyake, Izumi; Ohira, Miki; Nakagawara, Akira; Nakagawa, Atsuko; Sakai, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-222</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor originally identified as part of the chimeric nucleophosmin-ALK protein in the t(2;5) chromosomal rearrangement assocd. with anaplastic large cell lymphoma.  We recently demonstrated that the ALK kinase is constitutively activated by gene amplification at the ALK locus in several neuroblastoma cell lines.  Forming a stable complex with hyperphosphorylated ShcC, activated ALK modifies the responsiveness of the mitogen-activated protein kinase pathway to growth factors.  In the present study, the biol. role of activated ALK was examd. by suppressing the expression of ALK kinase in neuroblastoma cell lines using an RNA interference technique.  The suppression of activated ALK in neuroblastoma cells by RNA interference significantly reduced the phosphorylation of ShcC, mitogen-activated protein kinases, and Akt, inducing rapid apoptosis in the cells.  By immunohistochem. anal., the cytoplasmic expression of ALK was detected in most of the samples of neuroblastoma tissues regardless of the stage of the tumor, whereas significant amplification of ALK was obsd. in only 1 of 85 cases of human neuroblastoma samples.  These data demonstrate the limited frequency of ALK activation in the real progression of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3yzyhgfKX4rVg90H21EOLACvtfcHk0liUG6m0QKxRKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D&md5=591aceb254b3e707d315b6309ec5fba0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962966-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962966-5%26sid%3Dliteratum%253Aachs%26aulast%3DOsajima-Hakomori%26aufirst%3DY.%26aulast%3DMiyake%26aufirst%3DI.%26aulast%3DOhira%26aufirst%3DM.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DA.%26aulast%3DSakai%26aufirst%3DR.%26atitle%3DBiological%2520Role%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520in%2520Neuroblastoma%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D167%26spage%3D213%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mossé, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris., J. M.</span><span> </span><span class="NLM_article-title">Identification of <i>ALK</i> as a Major Familial Neuroblastoma Predisposition Gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&author=Y.+P.+Moss%C3%A9author=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris.&title=Identification+of+ALK+as+a+Major+Familial+Neuroblastoma+Predisposition+Gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%25C3%25A9%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris.%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520Major%2520Familial%2520Neuroblastoma%2520Predisposition%2520Gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. G.</span><span> </span><span class="NLM_article-title">Myelosuppression and Kinase Selectivity of Multikinase Angiogenesis Inhibitors</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1038%2Fsj.bjc.6605366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19844230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2hs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=1717-1723&author=R.+Kumarauthor=M.-C.+Crouthamelauthor=D.+H.+Romingerauthor=R.+R.+Gontarekauthor=P.+J.+Tumminoauthor=R.+A.+Levinauthor=A.+G.+King&title=Myelosuppression+and+Kinase+Selectivity+of+Multikinase+Angiogenesis+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors</span></div><div class="casAuthors">Kumar, R.; Crouthamel, M-C.; Rominger, D. H.; Gontarek, R. R.; Tummino, P. J.; Levin, R. A.; King, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1717-1723</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Myelosuppression has been obsd. with several multikinase angiogenesis inhibitors in clin. studies, although the frequency and severity varies among the different agents.  Inhibitors targeting vascular endothelial growth factor receptor (VEGFR) often inhibit other kinases, which may contribute to their adverse-event profiles.  Kinase selectivity of pazopanib, sorafenib, and sunitinib was evaluated in a panel of 242 kinases.  Cellular potency was measured using autophosphorylation assays.  Effect on human bone marrow progenitor growth in the presence of multiple growth factors was evaluated and correlated with the kinase selectivity.  Sunitinib inhibited more kinases than pazopanib and sorafenib, at potencies within 10-fold of VEGFR-2.  All three compds. potently inhibited VEGFR-2, platelet-derived growth factor receptor-β and c-Kit, However, pazopanib was less active against Flt-3 in both kinase and cellular assays.  The inhibitory properties of pazopanib, sorafenib, and sunitinib were dependent on the growth factor used to initiate bone marrow colony formation.  Addn. of stem cell factor and/or Flt-3 ligand with granulocyte-macrophage colony stimulating factor resulted in significant shifts in potency for sorafenib and sunitinib but less so for pazopanib.  Activity against c-kit and Flt-3 by multikinase angiogenesis inhibitors provide a potential explanation for the differences in myelosuppression obsd. with these agents in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyWQK5vGOgLLVg90H21EOLACvtfcHk0lgpLe7SqmYLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2hs7rL&md5=0ba9f0d114de4ac6b60f772b72719af5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605366%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DRominger%26aufirst%3DD.%2BH.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DLevin%26aufirst%3DR.%2BA.%26aulast%3DKing%26aufirst%3DA.%2BG.%26atitle%3DMyelosuppression%2520and%2520Kinase%2520Selectivity%2520of%2520Multikinase%2520Angiogenesis%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D1717%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Izzedine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rixe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billemont, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumelou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deray, G.</span><span> </span><span class="NLM_article-title">Angiogenesis Inhibitor Therapies: Focus on Kidney Toxicity and Hypertension</span> <span class="citation_source-journal">Am. J. Kidney Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1053%2Fj.ajkd.2007.04.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17660022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=203-218&author=H.+Izzedineauthor=O.+Rixeauthor=B.+Billemontauthor=A.+Baumelouauthor=G.+Deray&title=Angiogenesis+Inhibitor+Therapies%3A+Focus+on+Kidney+Toxicity+and+Hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension</span></div><div class="casAuthors">Izzedine, Hassane; Rixe, Olivier; Billemont, Bertrand; Baumelou, Alain; Deray, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-218</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Angiogenesis inhibitors that target the epidermal growth factor (EGF) receptor (EGFR) and vascular endothelial growth factor (VEGF) constitute an important addn. to the therapeutic armamentarium for the treatment of patients with metastatic disease.  However, because the same growth factors are expressed in the kidneys, these treatment mols. have renal side effects.  EGFR is expressed mainly in tubules (mainly distal and collecting segments) and mesangial and parietal epithelial cells.  EGF is involved in maintaining tubular integrity and is a potent mitogen for cultured mesangial cells.  Few cases of acute renal failure have been reported related to EGFR inhibitors.  VEGF and VEGF receptors are still highly expressed in the kidney.  VEGF is expressed in podocytes in the glomerulus, and VEGF receptors are present on endothelial, mesangial, and peritubular capillary cells.  Signaling between endothelial cells and podocytes is essential for the proper development and maintenance of the filtration function of the kidney glomerulus.  The most common renal class effects of VEGF antagonists are both manageable; hypertension and proteinuria commonly regressive on drug withdrawal.  There was a dose-dependent increase in risk of proteinuria and hypertension in patients with cancer who received targeted therapies.  Furthermore, few patients with glomerulonephritis or thrombotic microangiopathy secondary to treatment were reported.  Hypertension is believed to be nitric oxide dependent, whereas proteinuria seems to be related to downregulation of podocyte tight junction protein.  This article reviews data relating to hypertension and proteinuria assocd. with the use of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7CD4vNf1df7Vg90H21EOLACvtfcHk0lgpLe7SqmYLlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7rI&md5=bd6eddeff7e7146eada7c1b4b3fedb5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2007.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2007.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DIzzedine%26aufirst%3DH.%26aulast%3DRixe%26aufirst%3DO.%26aulast%3DBillemont%26aufirst%3DB.%26aulast%3DBaumelou%26aufirst%3DA.%26aulast%3DDeray%26aufirst%3DG.%26atitle%3DAngiogenesis%2520Inhibitor%2520Therapies%253A%2520Focus%2520on%2520Kidney%2520Toxicity%2520and%2520Hypertension%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2007%26volume%3D50%26spage%3D203%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crizotinib, A</span><span> </span><span class="NLM_article-title">Small-Molecule Dual Inhibitor of the c-Met and ALK Receptor Tyrosine Kinases</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1477</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1477-1490&author=S.+J.+Rodigauthor=G.+I.+Shapiroauthor=A+Crizotinib&title=Small-Molecule+Dual+Inhibitor+of+the+c-Met+and+ALK+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DCrizotinib%26aufirst%3DA%26atitle%3DSmall-Molecule%2520Dual%2520Inhibitor%2520of%2520the%2520c-Met%2520and%2520ALK%2520Receptor%2520Tyrosine%2520Kinases%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D1477%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">Discovery of Novel Tetracyclic Compounds as Anaplastic Lymphoma Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3788</span><span class="NLM_x">–</span> <span class="NLM_lpage">3793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3788-3793&author=K.+Kinoshitaauthor=Y.+Onoauthor=T.+Emuraauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Tanakaauthor=K.+Morikamiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=Discovery+of+Novel+Tetracyclic+Compounds+as+Anaplastic+Lymphoma+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520Novel%2520Tetracyclic%2520Compounds%2520as%2520Anaplastic%2520Lymphoma%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3788%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kinoshita, K.; Asoh, K.; Furuichi, N.; Ito, T.; Kawada, H.; Ishii, N.; Sakamoto, H.; Hong, W. S.; Park, M. J.; Ono, Y.; Kato, Y.; Morikami, K.; Emura, T.; Oikawa, N.</span><span> </span><span class="NLM_article-title">Tetracyclic Compound</span>. PCT Int. Appl. WO2010/143664,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+Kinoshita&author=K.+Asoh&author=N.+Furuichi&author=T.+Ito&author=H.+Kawada&author=N.+Ishii&author=H.+Sakamoto&author=W.+S.+Hong&author=M.+J.+Park&author=Y.+Ono&author=Y.+Kato&author=K.+Morikami&author=T.+Emura&author=N.+Oikawa&title=Tetracyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26atitle%3DTetracyclic%2520Compound%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Hart, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-Y.</span><span> </span><span class="NLM_article-title">Alkylation of Phenol with a Homoallylic Halide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3269</span><span class="NLM_x">–</span> <span class="NLM_lpage">3273</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00903a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=3269-3273&author=H.+Hartauthor=J.+L.+Corbinauthor=C.+R.+Wagnerauthor=C.-Y.+Wu&title=Alkylation+of+Phenol+with+a+Homoallylic+Halide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja00903a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00903a047%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DH.%26aulast%3DCorbin%26aufirst%3DJ.%2BL.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DWu%26aufirst%3DC.-Y.%26atitle%3DAlkylation%2520of%2520Phenol%2520with%2520a%2520Homoallylic%2520Halide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26spage%3D3269%26epage%3D3273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liao, J. J. L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.+L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lgaZ2jV0LHBog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.%2BL.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">This is the result of our kinase database search. The names and amino acid sequences of ATP binding pocket of the 14 kinases are described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span> </span><span class="NLM_article-title">CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=679-690&author=H.+Sakamotoauthor=T.+Tsukaguchiauthor=S.+Hiroshimaauthor=T.+Kodamaauthor=T.+Kobayashiauthor=T.+A.+Fukamiauthor=N.+Oikawaauthor=T.+Tsukudaauthor=N.+Ishiiauthor=Y.+Aoki&title=CH5424802%2C+a+Selective+ALK+Inhibitor+Capable+of+Blocking+the+Resistant+Gatekeeper+Mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DHiroshima%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%2BA.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26atitle%3DCH5424802%252C%2520a%2520Selective%2520ALK%2520Inhibitor%2520Capable%2520of%2520Blocking%2520the%2520Resistant%2520Gatekeeper%2520Mutant%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">The complex model was prepared using the Molecular Operating Environment software package (MOE 2010.10; Chemical Computing Group Inc., Montreal, Quebec.). The cocrystal structure of human ALK in complex with CH5424802 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AOX">3AOX</a>) was used to construct complex models of compound <b>13a</b>. Compound <b>13a</b> was derived by modifying the original ligand. The missing atoms of human ALK were constructed with reference to other human ALK crystal structures (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCS">3LCS</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2">2XP2</a>). Solvent molecules within a distance of 5.0 Å around the original ligand were kept. All hydrogen atoms and modified parts of ligand were subjected to energy minimization using MMFF94x force field parameters in combination with GBSA solvent model. The final root-mean-square gradient was set to 0.001.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fischer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacheva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhoe, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpas, A.</span><span> </span><span class="NLM_article-title">A Ki-1 (CD30)-positive Human Cell Line (Karpas 299) Established from a High-Grade Non-Hodgkin’s Lymphoma, Showing a 2;5 Translocation and Rearrangement of the T-Cell Receptor Beta-Chain Gene</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1988&pages=234-240&author=P.+Fischerauthor=E.+Nachevaauthor=D.+Y.+Masonauthor=P.+D.+Sherringtonauthor=C.+Hoyleauthor=F.+G.+Hayhoeauthor=A.+Karpas&title=A+Ki-1+%28CD30%29-positive+Human+Cell+Line+%28Karpas+299%29+Established+from+a+High-Grade+Non-Hodgkin%E2%80%99s+Lymphoma%2C+Showing+a+2%3B5+Translocation+and+Rearrangement+of+the+T-Cell+Receptor+Beta-Chain+Gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%26aulast%3DNacheva%26aufirst%3DE.%26aulast%3DMason%26aufirst%3DD.%2BY.%26aulast%3DSherrington%26aufirst%3DP.%2BD.%26aulast%3DHoyle%26aufirst%3DC.%26aulast%3DHayhoe%26aufirst%3DF.%2BG.%26aulast%3DKarpas%26aufirst%3DA.%26atitle%3DA%2520Ki-1%2520%2528CD30%2529-positive%2520Human%2520Cell%2520Line%2520%2528Karpas%2520299%2529%2520Established%2520from%2520a%2520High-Grade%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%252C%2520Showing%2520a%25202%253B5%2520Translocation%2520and%2520Rearrangement%2520of%2520the%2520T-Cell%2520Receptor%2520Beta-Chain%2520Gene%26jtitle%3DBlood%26date%3D1988%26volume%3D72%26spage%3D234%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':[],'ref23':['cit23'],'ref24':[],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 53 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shaowen Xie, Yuan Sun, Yulin Liu, Xinnan Li, Xinuo Li, Wenyi Zhong, Feiyan Zhan, Jingjie Zhu, Hong Yao, Dong-Hua Yang, Zhe-Sheng Chen, Jinyi Xu, <span class="NLM_string-name hlFld-ContribAuthor">Shengtao Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Alectinib-Based PROTACs as Novel Potent Degraders of Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9120-9140. <a href="https://doi.org/10.1021/acs.jmedchem.1c00270" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00270</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00270&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00270%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BAlectinib-Based%252BPROTACs%252Bas%252BNovel%252BPotent%252BDegraders%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DXie%26aufirst%3DShaowen%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D11022021%26date%3D28062021%26volume%3D64%26issue%3D13%26spage%3D9120%26epage%3D9140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianyong Chen, Yunlong Zhou, Xuyuan Dong, Liu Liu, Longchuan Bai, Donna McEachern, Sally Przybranowski, Chao-Yie Yang, Jeanne Stuckey, Xiaoqin Li, Bo Wen, Ting Zhao, Siwei Sun, Duxin Sun, Lingling Jiao, Yu Jing, Ming Guo, Dajun Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13994-14016. <a href="https://doi.org/10.1021/acs.jmedchem.0c01550" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01550</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01550%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BCJ-2360%252Bas%252Ba%252BPotent%252Band%252BOrally%252BActive%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252BCapable%252Bof%252BAchieving%252BComplete%252BTumor%252BRegression%26aulast%3DChen%26aufirst%3DJianyong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D04092020%26date%3D13112020%26volume%3D63%26issue%3D22%26spage%3D13994%26epage%3D14016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaotian Kong, Peichen Pan, Huiyong Sun, Hongguang Xia, Xuwen Wang, Youyong Li, <span class="NLM_string-name hlFld-ContribAuthor">Tingjun Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (24)
                                     , 10927-10954. <a href="https://doi.org/10.1021/acs.jmedchem.9b00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDrug%252BDiscovery%252BTargeting%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DKong%26aufirst%3DXiaotian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14032019%26date%3D26082019%26date%3D16082019%26volume%3D62%26issue%3D24%26spage%3D10927%26epage%3D10954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ellen Watts, David Heidenreich, Elizabeth Tucker, Monika Raab, Klaus Strebhardt, Louis Chesler, Stefan Knapp, Benjamin Bellenie, <span class="NLM_string-name hlFld-ContribAuthor">Swen Hoelder</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2618-2637. <a href="https://doi.org/10.1021/acs.jmedchem.8b01947" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01947%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252BDual%252BInhibitors%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252Band%252BBromodomain-4%252B%252528BRD4%252529%252Bby%252BTuning%252BKinase%252BSelectivity%26aulast%3DWatts%26aufirst%3DEllen%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D13122018%26date%3D21022019%26volume%3D62%26issue%3D5%26spage%3D2618%26epage%3D2637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Robert    Dugger </span><span class="hlFld-ContribAuthor "> Bryan    Li    </span><span class="hlFld-ContribAuthor "> Paul    Richardson </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Lorlatinib: A Macrocyclic Inhibitor of EML4-ALK for the Treatment of NSCLC. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 27-59. <a href="https://doi.org/10.1021/bk-2019-1332.ch002" title="DOI URL">https://doi.org/10.1021/bk-2019-1332.ch002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2019-1332.ch002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2019-1332.ch002%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BLorlatinib%25253A%252BA%252BMacrocyclic%252BInhibitor%252Bof%252BEML4-ALK%252Bfor%252Bthe%252BTreatment%252Bof%252BNSCLC%26aulast%3DDugger%26aufirst%3DRobert%26date%3D2019%26date%3D2019%26spage%3D27%26epage%3D59%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B2%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2019%26date%3D2019%26volume%3D1332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ted W. Johnson, Ben Bolanos, Alexei Brooun, Rebecca A. Gallego, Dan Gehlhaar, Mehran Jalaie, Michele McTigue, <span class="NLM_string-name hlFld-ContribAuthor">Sergei Timofeevski</span>. </span><span class="cited-content_cbyCitation_article-title">Reviving B-Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (9)
                                     , 872-877. <a href="https://doi.org/10.1021/acsmedchemlett.8b00348" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00348%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DReviving%252BB-Factors%25253A%252BActivating%252BALK%252BMutations%252BIncrease%252BProtein%252BDynamics%252Bof%252Bthe%252BUnphosphorylated%252BKinase%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31072018%26date%3D24082018%26date%3D28082018%26date%3D24082018%26volume%3D9%26issue%3D9%26spage%3D872%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David L.  Hughes</span>  . </span><span class="cited-content_cbyCitation_article-title">Patent Review of Manufacturing Routes to Recently Approved Oncology Drugs: Ibrutinib, Cobimetinib, and Alectinib. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2016,</strong> <em>20 </em>
                                    (11)
                                     , 1855-1869. <a href="https://doi.org/10.1021/acs.oprd.6b00304" title="DOI URL">https://doi.org/10.1021/acs.oprd.6b00304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.6b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.6b00304%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DPatent%252BReview%252Bof%252BManufacturing%252BRoutes%252Bto%252BRecently%252BApproved%252BOncology%252BDrugs%25253A%252BIbrutinib%25252C%252BCobimetinib%25252C%252Band%252BAlectinib%26aulast%3DHughes%26aufirst%3DDavid%2BL.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D08092016%26date%3D09112016%26date%3D18112016%26date%3D10102016%26volume%3D20%26issue%3D11%26spage%3D1855%26epage%3D1869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Bull</span>, <span class="hlFld-ContribAuthor ">Rosemary A.  Croft</span>, <span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">Robert  Doran</span>, and <span class="hlFld-ContribAuthor ">Kate F.  Morgan</span>  . </span><span class="cited-content_cbyCitation_article-title">Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12150-12233. <a href="https://doi.org/10.1021/acs.chemrev.6b00274" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00274%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DOxetanes%25253A%252BRecent%252BAdvances%252Bin%252BSynthesis%25252C%252BReactivity%25252C%252Band%252BMedicinal%252BChemistry%26aulast%3DBull%26aufirst%3DJames%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28042016%26date%3D15092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12150%26epage%3D12233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Menichincheri</span>, <span class="hlFld-ContribAuthor ">Elena  Ardini</span>, <span class="hlFld-ContribAuthor ">Paola  Magnaghi</span>, <span class="hlFld-ContribAuthor ">Nilla  Avanzi</span>, <span class="hlFld-ContribAuthor ">Patrizia  Banfi</span>, <span class="hlFld-ContribAuthor ">Roberto  Bossi</span>, <span class="hlFld-ContribAuthor ">Laura  Buffa</span>, <span class="hlFld-ContribAuthor ">Giulia  Canevari</span>, <span class="hlFld-ContribAuthor ">Lucio  Ceriani</span>, <span class="hlFld-ContribAuthor ">Maristella  Colombo</span>, <span class="hlFld-ContribAuthor ">Luca  Corti</span>, <span class="hlFld-ContribAuthor ">Daniele  Donati</span>, <span class="hlFld-ContribAuthor ">Marina  Fasolini</span>, <span class="hlFld-ContribAuthor ">Eduard  Felder</span>, <span class="hlFld-ContribAuthor ">Claudio  Fiorelli</span>, <span class="hlFld-ContribAuthor ">Francesco  Fiorentini</span>, <span class="hlFld-ContribAuthor ">Arturo  Galvani</span>, <span class="hlFld-ContribAuthor ">Antonella  Isacchi</span>, <span class="hlFld-ContribAuthor ">Andrea Lombardi  Borgia</span>, <span class="hlFld-ContribAuthor ">Chiara  Marchionni</span>, <span class="hlFld-ContribAuthor ">Marcella  Nesi</span>, <span class="hlFld-ContribAuthor ">Christian  Orrenius</span>, <span class="hlFld-ContribAuthor ">Achille  Panzeri</span>, <span class="hlFld-ContribAuthor ">Enrico  Pesenti</span>, <span class="hlFld-ContribAuthor ">Luisa  Rusconi</span>, <span class="hlFld-ContribAuthor ">Maria Beatrice  Saccardo</span>, <span class="hlFld-ContribAuthor ">Ermes  Vanotti</span>, <span class="hlFld-ContribAuthor ">Ettore  Perrone</span>, and <span class="hlFld-ContribAuthor ">Paolo  Orsini</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3392-3408. <a href="https://doi.org/10.1021/acs.jmedchem.6b00064" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00064%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BEntrectinib%25253A%252BA%252BNew%252B3-Aminoindazole%252BAs%252Ba%252BPotent%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%25252C%252Bc-ros%252BOncogene%252B1%252BKinase%252B%252528ROS1%252529%25252C%252Band%252BPan-Tropomyosin%252BReceptor%252BKinases%252B%252528Pan-TRKs%252529%252Binhibitor%26aulast%3DMenichincheri%26aufirst%3DMaria%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14012016%26date%3D30032016%26date%3D14042016%26date%3D22032016%26volume%3D59%26issue%3D7%26spage%3D3392%26epage%3D3408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Yanhong  Yang</span>, <span class="hlFld-ContribAuthor ">Zhiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Junfeng  Guo</span>, <span class="hlFld-ContribAuthor ">Xinying  Yang</span>, <span class="hlFld-ContribAuthor ">Kui  Wu</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, and <span class="hlFld-ContribAuthor ">Ao  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against Both Wild-type and Mutant ALK Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 197-211. <a href="https://doi.org/10.1021/jm5005144" title="DOI URL">https://doi.org/10.1021/jm5005144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5005144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5005144%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252B2%25252C4-Diarylaminopyrimidine%252BAnalogues%252B%252528DAAPalogues%252529%252BShowing%252BPotent%252BInhibitory%252BActivities%252Bagainst%252BBoth%252BWild-type%252Band%252BMutant%252BALK%252BKinases%26aulast%3DSong%26aufirst%3DZilan%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D01042014%26date%3D08052014%26date%3D08012015%26date%3D30042014%26volume%3D58%26issue%3D1%26spage%3D197%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ted W.  Johnson</span>, <span class="hlFld-ContribAuthor ">Paul F.  Richardson</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">Alexei  Brooun</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Burke</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">J. Jean  Cui</span>, <span class="hlFld-ContribAuthor ">Judith G.  Deal</span>, <span class="hlFld-ContribAuthor ">Ya-Li  Deng</span>, <span class="hlFld-ContribAuthor ">Dac  Dinh</span>, <span class="hlFld-ContribAuthor ">Lars D.  Engstrom</span>, <span class="hlFld-ContribAuthor ">Mingying  He</span>, <span class="hlFld-ContribAuthor ">Jacqui  Hoffman</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Qinhua  Huang</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kania</span>, <span class="hlFld-ContribAuthor ">John C.  Kath</span>, <span class="hlFld-ContribAuthor ">Hieu  Lam</span>, <span class="hlFld-ContribAuthor ">Justine L.  Lam</span>, <span class="hlFld-ContribAuthor ">Phuong T.  Le</span>, <span class="hlFld-ContribAuthor ">Laura  Lingardo</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Michele  McTigue</span>, <span class="hlFld-ContribAuthor ">Cynthia L.  Palmer</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Tod  Smeal</span>, <span class="hlFld-ContribAuthor ">Graham L.  Smith</span>, <span class="hlFld-ContribAuthor ">Albert E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Sergei  Timofeevski</span>, <span class="hlFld-ContribAuthor ">Huichun  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinjiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Helen Y.  Zou</span>, and <span class="hlFld-ContribAuthor ">Martin P.  Edwards</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4720-4744. <a href="https://doi.org/10.1021/jm500261q" title="DOI URL">https://doi.org/10.1021/jm500261q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500261q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%25252810R%252529-7-Amino-12-fluoro-2%25252C10%25252C16-trimethyl-15-oxo-10%25252C15%25252C16%25252C17-tetrahydro-2H-8%25252C4-%252528metheno%252529pyrazolo%25255B4%25252C3-h%25255D%25255B2%25252C5%25252C11%25255D-benzoxadiazacyclotetradecine-3-carbonitrile%252B%252528PF-06463922%252529%25252C%252Ba%252BMacrocyclic%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252Band%252Bc-ros%252BOncogene%252B1%252B%252528ROS1%252529%252Bwith%252BPreclinical%252BBrain%252BExposure%252Band%252BBroad-Spectrum%252BPotency%252Bagainst%252BALK-Resistant%252BMutations%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17022014%26date%3D03062014%26date%3D12062014%26date%3D13052014%26volume%3D57%26issue%3D11%26spage%3D4720%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinhua  Huang</span>, <span class="hlFld-ContribAuthor ">Ted W.  Johnson</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">Alexei  Brooun</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Bunker</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Burke</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Cook</span>, <span class="hlFld-ContribAuthor ">J. Jean  Cui</span>, <span class="hlFld-ContribAuthor ">Kevin N.  Dack</span>, <span class="hlFld-ContribAuthor ">Judith G.  Deal</span>, <span class="hlFld-ContribAuthor ">Ya-Li  Deng</span>, <span class="hlFld-ContribAuthor ">Dac  Dinh</span>, <span class="hlFld-ContribAuthor ">Lars D.  Engstrom</span>, <span class="hlFld-ContribAuthor ">Mingying  He</span>, <span class="hlFld-ContribAuthor ">Jacqui  Hoffman</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Patrick S.  Johnson</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kania</span>, <span class="hlFld-ContribAuthor ">Hieu  Lam</span>, <span class="hlFld-ContribAuthor ">Justine L.  Lam</span>, <span class="hlFld-ContribAuthor ">Phuong T.  Le</span>, <span class="hlFld-ContribAuthor ">Qiuhua  Li</span>, <span class="hlFld-ContribAuthor ">Laura  Lingardo</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Melissa West  Lu</span>, <span class="hlFld-ContribAuthor ">Michele  McTigue</span>, <span class="hlFld-ContribAuthor ">Cynthia L.  Palmer</span>, <span class="hlFld-ContribAuthor ">Paul F.  Richardson</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Hong  Shen</span>, <span class="hlFld-ContribAuthor ">Tod  Smeal</span>, <span class="hlFld-ContribAuthor ">Graham L.  Smith</span>, <span class="hlFld-ContribAuthor ">Albert E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Sergei  Timofeevski</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Tsaparikos</span>, <span class="hlFld-ContribAuthor ">Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Huichun  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinjiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Helen Y.  Zou</span>, and <span class="hlFld-ContribAuthor ">Martin P.  Edwards</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Potent and Selective Inhibitors to Overcome Clinical Anaplastic Lymphoma Kinase Mutations Resistant to Crizotinib. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1170-1187. <a href="https://doi.org/10.1021/jm401805h" title="DOI URL">https://doi.org/10.1021/jm401805h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401805h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401805h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BPotent%252Band%252BSelective%252BInhibitors%252Bto%252BOvercome%252BClinical%252BAnaplastic%252BLymphoma%252BKinase%252BMutations%252BResistant%252Bto%252BCrizotinib%26aulast%3DHuang%26aufirst%3DQinhua%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D22112013%26date%3D06022014%26date%3D27022014%26date%3D16012014%26volume%3D57%26issue%3D4%26spage%3D1170%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas H.  Marsilje</span>, <span class="hlFld-ContribAuthor ">Wei  Pei</span>, <span class="hlFld-ContribAuthor ">Bei  Chen</span>, <span class="hlFld-ContribAuthor ">Wenshuo  Lu</span>, <span class="hlFld-ContribAuthor ">Tetsuo  Uno</span>, <span class="hlFld-ContribAuthor ">Yunho  Jin</span>, <span class="hlFld-ContribAuthor ">Tao  Jiang</span>, <span class="hlFld-ContribAuthor ">Sungjoon  Kim</span>, <span class="hlFld-ContribAuthor ">Nanxin  Li</span>, <span class="hlFld-ContribAuthor ">Markus  Warmuth</span>, <span class="hlFld-ContribAuthor ">Yelena  Sarkisova</span>, <span class="hlFld-ContribAuthor ">Frank  Sun</span>, <span class="hlFld-ContribAuthor ">Auzon  Steffy</span>, <span class="hlFld-ContribAuthor ">AnneMarie C.  Pferdekamper</span>, <span class="hlFld-ContribAuthor ">Allen G.  Li</span>, <span class="hlFld-ContribAuthor ">Sean B.  Joseph</span>, <span class="hlFld-ContribAuthor ">Young  Kim</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Tove  Tuntland</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Cui</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Ruo  Steensma</span>, <span class="hlFld-ContribAuthor ">Yongqin  Wan</span>, <span class="hlFld-ContribAuthor ">Jiqing  Jiang</span>, <span class="hlFld-ContribAuthor ">Greg  Chopiuk</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">W. Perry  Gordon</span>, <span class="hlFld-ContribAuthor ">Wendy  Richmond</span>, <span class="hlFld-ContribAuthor ">Kevin  Johnson</span>, <span class="hlFld-ContribAuthor ">Jonathan  Chang</span>, <span class="hlFld-ContribAuthor ">Todd  Groessl</span>, <span class="hlFld-ContribAuthor ">You-Qun  He</span>, <span class="hlFld-ContribAuthor ">Andrew  Phimister</span>, <span class="hlFld-ContribAuthor ">Alex  Aycinena</span>, <span class="hlFld-ContribAuthor ">Christian C.  Lee</span>, <span class="hlFld-ContribAuthor ">Badry  Bursulaya</span>, <span class="hlFld-ContribAuthor ">Donald S.  Karanewsky</span>, <span class="hlFld-ContribAuthor ">H. Martin  Seidel</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Harris</span>, and <span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Structure–Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (14)
                                     , 5675-5690. <a href="https://doi.org/10.1021/jm400402q" title="DOI URL">https://doi.org/10.1021/jm400402q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400402q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400402q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BStructure%2525E2%252580%252593Activity%252BRelationships%25252C%252Band%252Bin%252BVivo%252BEfficacy%252Bof%252Bthe%252BNovel%252BPotent%252Band%252BSelective%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BInhibitor%252B5-Chloro-N2-%2525282-isopropoxy-5-methyl-4-%252528piperidin-4-yl%252529phenyl%252529-N4-%2525282-%252528isopropylsulfonyl%252529phenyl%252529pyrimidine-2%25252C4-diamine%252B%252528LDK378%252529%252BCurrently%252Bin%252BPhase%252B1%252Band%252BPhase%252B2%252BClinical%252BTrials%26aulast%3DMarsilje%26aufirst%3DThomas%2BH.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D19032013%26date%3D26062013%26date%3D25072013%26date%3D06062013%26volume%3D56%26issue%3D14%26spage%3D5675%26epage%3D5690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Yueshan  Li</span>, <span class="hlFld-ContribAuthor ">Liang  Xiong</span>, <span class="hlFld-ContribAuthor ">Wenjing  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Ting  Yuan</span>, <span class="hlFld-ContribAuthor ">Wei  Yang</span>, <span class="hlFld-ContribAuthor ">Chenyu  Tian</span>, <span class="hlFld-ContribAuthor ">Zhuang  Miao</span>, <span class="hlFld-ContribAuthor ">Tianqi  Wang</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-021-00572-w" title="DOI URL">https://doi.org/10.1038/s41392-021-00572-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-021-00572-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-021-00572-w%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DSmall%252Bmolecules%252Bin%252Btargeted%252Bcancer%252Btherapy%25253A%252Badvances%25252C%252Bchallenges%25252C%252Band%252Bfuture%252Bperspectives%26aulast%3DZhong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Feng  Wu</span>, <span class="hlFld-ContribAuthor ">Han  Yao</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Niuniu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangyang  Fan</span>, <span class="hlFld-ContribAuthor ">Albert S.C.  Chan</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Baijiao  An</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing a sulfoxide moiety as anaplastic lymphoma kinase (ALK) inhibition agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>48 </em>, 128253. <a href="https://doi.org/10.1016/j.bmcl.2021.128253" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128253%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B2%25252C4-diaminopyrimidines%252Bbearing%252Ba%252Bsulfoxide%252Bmoiety%252Bas%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibition%252Bagents%26aulast%3DWu%26aufirst%3DFeng%26date%3D2021%26volume%3D48%26spage%3D128253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoxia  Liang</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Pan  Wu</span>, <span class="hlFld-ContribAuthor ">Changliang  He</span>, <span class="hlFld-ContribAuthor ">Lizi  Yin</span>, <span class="hlFld-ContribAuthor ">Funeng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhongqiong  Yin</span>, <span class="hlFld-ContribAuthor ">Guizhou  Yue</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Lixia  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Song</span>, <span class="hlFld-ContribAuthor ">Cheng  Lv</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Jing</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis review of the approved tyrosine kinase inhibitors for anticancer therapy in 2015–2020. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 105011. <a href="https://doi.org/10.1016/j.bioorg.2021.105011" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Breview%252Bof%252Bthe%252Bapproved%252Btyrosine%252Bkinase%252Binhibitors%252Bfor%252Banticancer%252Btherapy%252Bin%252B2015%2525E2%252580%2525932020%26aulast%3DLiang%26aufirst%3DXiaoxia%26date%3D2021%26volume%3D113%26spage%3D105011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Wang</span>, <span class="hlFld-ContribAuthor ">Shi‐Chao  Wang</span>, <span class="hlFld-ContribAuthor ">Wen‐Juan  Hao</span>, <span class="hlFld-ContribAuthor ">Shu‐Jiang  Tu</span>, <span class="hlFld-ContribAuthor ">Bo  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Syntheses of Benzo[
              b
              ]carbazoles and C3‐Substituted Indoles
              via
              Tunable Catalytic Annulations of
              β
              ‐Alkynyl Ketones with Indoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (16)
                                     , 3416-3422. <a href="https://doi.org/10.1002/adsc.202000491" title="DOI URL">https://doi.org/10.1002/adsc.202000491</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000491%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSelective%252BSyntheses%252Bof%252BBenzo%25255B%252Bb%252B%25255Dcarbazoles%252Band%252BC3%2525E2%252580%252590Substituted%252BIndoles%252Bvia%252BTunable%252BCatalytic%252BAnnulations%252Bof%252B%2525CE%2525B2%252B%2525E2%252580%252590Alkynyl%252BKetones%252Bwith%252BIndoles%26aulast%3DWang%26aufirst%3DDan%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D16%26spage%3D3416%26epage%3D3422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jyothi  Dhuguru</span>, <span class="hlFld-ContribAuthor ">Rachid  Skouta</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Indole Scaffolds as Pharmacophores in the Development of Anti-Lung Cancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1615. <a href="https://doi.org/10.3390/molecules25071615" title="DOI URL">https://doi.org/10.3390/molecules25071615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071615%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRole%252Bof%252BIndole%252BScaffolds%252Bas%252BPharmacophores%252Bin%252Bthe%252BDevelopment%252Bof%252BAnti-Lung%252BCancer%252BAgents%26aulast%3DDhuguru%26aufirst%3DJyothi%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Anusha</span>, <span class="hlFld-ContribAuthor ">S.  Sharanya</span>, <span class="hlFld-ContribAuthor ">Ramya  Ramya</span>, <span class="hlFld-ContribAuthor ">Darling Chellathai  David</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Screening of the Phytochemicals Present in the Medicinal Plant Vitex Negundo Against Mutant Anaplastic Lymphoma Kinase (ALK) Protein: An In-Silico Approach. </span><span class="cited-content_cbyCitation_journal-name">Biomedical and Pharmacology Journal</span><span> <strong>2019,</strong> <em>12 </em>
                                    (2)
                                     , 993-1000. <a href="https://doi.org/10.13005/bpj/1727" title="DOI URL">https://doi.org/10.13005/bpj/1727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.13005/bpj/1727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.13005%2Fbpj%2F1727%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedical%2520and%2520Pharmacology%2520Journal%26atitle%3DAnticancer%252BScreening%252Bof%252Bthe%252BPhytochemicals%252BPresent%252Bin%252Bthe%252BMedicinal%252BPlant%252BVitex%252BNegundo%252BAgainst%252BMutant%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252BProtein%25253A%252BAn%252BIn-Silico%252BApproach%26aulast%3DAnusha%26aufirst%3DD.%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D2%26spage%3D993%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yantao  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Methylation: A Guide for Selecting Methylation Reagents. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (14)
                                     , 3405-3439. <a href="https://doi.org/10.1002/chem.201803642" title="DOI URL">https://doi.org/10.1002/chem.201803642</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201803642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201803642%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DRecent%252BAdvances%252Bin%252BMethylation%25253A%252BA%252BGuide%252Bfor%252BSelecting%252BMethylation%252BReagents%26aulast%3DChen%26aufirst%3DYantao%26date%3D2019%26date%3D2018%26volume%3D25%26issue%3D14%26spage%3D3405%26epage%3D3439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Danilo  Rocco</span>, <span class="hlFld-ContribAuthor ">Ciro  Battiloro</span>, <span class="hlFld-ContribAuthor ">Luigi  Della Gravara</span>, <span class="hlFld-ContribAuthor ">Cesare  Gridelli</span>. </span><span class="cited-content_cbyCitation_article-title">Safety and Tolerability of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer. </span><span class="cited-content_cbyCitation_journal-name">Drug Safety</span><span> <strong>2019,</strong> <em>42 </em>
                                    (2)
                                     , 199-209. <a href="https://doi.org/10.1007/s40264-018-0771-y" title="DOI URL">https://doi.org/10.1007/s40264-018-0771-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40264-018-0771-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40264-018-0771-y%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Safety%26atitle%3DSafety%252Band%252BTolerability%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252BInhibitors%252Bin%252BNon-Small-Cell%252BLung%252BCancer%26aulast%3DRocco%26aufirst%3DDanilo%26date%3D2019%26date%3D2019%26volume%3D42%26issue%3D2%26spage%3D199%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rasa  Keruckienė</span>, <span class="hlFld-ContribAuthor ">Dmytro  Volyniuk</span>, <span class="hlFld-ContribAuthor ">Oleksandr  Bezvikonnyi</span>, <span class="hlFld-ContribAuthor ">Naveen  Masimukku</span>, <span class="hlFld-ContribAuthor ">Khrystyna  Ivaniuk</span>, <span class="hlFld-ContribAuthor ">Pavlo  Stakhira</span>, <span class="hlFld-ContribAuthor ">Juozas Vidas  Gražulevičius</span>. </span><span class="cited-content_cbyCitation_article-title">Benzo[b]carbazole and indole derivatives as emitters for non-doped deep-blue organic light emitting diodes. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2018,</strong> <em>154 </em>, 145-154. <a href="https://doi.org/10.1016/j.dyepig.2018.02.049" title="DOI URL">https://doi.org/10.1016/j.dyepig.2018.02.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2018.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2018.02.049%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3DBenzo%25255Bb%25255Dcarbazole%252Band%252Bindole%252Bderivatives%252Bas%252Bemitters%252Bfor%252Bnon-doped%252Bdeep-blue%252Borganic%252Blight%252Bemitting%252Bdiodes%26aulast%3DKeruckien%25C4%2597%26aufirst%3DRasa%26date%3D2018%26volume%3D154%26spage%3D145%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muyang  He</span>, <span class="hlFld-ContribAuthor ">Weikang  Li</span>, <span class="hlFld-ContribAuthor ">Qingchuan  Zheng</span>, <span class="hlFld-ContribAuthor ">Hongxing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A molecular dynamics investigation into the mechanisms of alectinib resistance of three ALK mutants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2018,</strong> <em>119 </em>
                                    (7)
                                     , 5332-5342. <a href="https://doi.org/10.1002/jcb.26666" title="DOI URL">https://doi.org/10.1002/jcb.26666</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.26666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.26666%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DA%252Bmolecular%252Bdynamics%252Binvestigation%252Binto%252Bthe%252Bmechanisms%252Bof%252Balectinib%252Bresistance%252Bof%252Bthree%252BALK%252Bmutants%26aulast%3DHe%26aufirst%3DMuyang%26date%3D2018%26date%3D2018%26volume%3D119%26issue%3D7%26spage%3D5332%26epage%3D5342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Wu</span>, <span class="hlFld-ContribAuthor ">Amit  Choudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitor Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 65-93. <a href="https://doi.org/10.1002/9783527808694.ch3" title="DOI URL">https://doi.org/10.1002/9783527808694.ch3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527808694.ch3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527808694.ch3%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitor%252BDrugs%26aulast%3DWu%26aufirst%3DPeng%26date%3D2018%26date%3D2018%26spage%3D65%26epage%3D93%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2018%26volume%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>. </span><span class="cited-content_cbyCitation_article-title">Ceritinib: A Potent ALK Inhibitor for the Treatment of Crizotinib-Resistant Non-Small Cell Lung Cancer Tumors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 131-152. <a href="https://doi.org/10.1002/9783527808694.ch6" title="DOI URL">https://doi.org/10.1002/9783527808694.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527808694.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527808694.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DCeritinib%25253A%252BA%252BPotent%252BALK%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCrizotinib-Resistant%252BNon-Small%252BCell%252BLung%252BCancer%252BTumors%26aulast%3DMichellys%26aufirst%3DPierre-Yves%26date%3D2018%26date%3D2018%26spage%3D131%26epage%3D152%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DSuccessful%252BDrug%252BDiscovery%26aulast%3DFischer%26aufirst%3DJ%25C3%25A1nos%26date%3D2018%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Latif</span>, <span class="hlFld-ContribAuthor ">Zaman  Ashraf</span>, <span class="hlFld-ContribAuthor ">Sulman  Basit</span>, <span class="hlFld-ContribAuthor ">Abdul  Ghaffar</span>, <span class="hlFld-ContribAuthor ">Muhammad Sohail  Zafar</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>, <span class="hlFld-ContribAuthor ">Sultan Ayoub  Meo</span>. </span><span class="cited-content_cbyCitation_article-title">Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (30)
                                     , 16470-16493. <a href="https://doi.org/10.1039/C8RA01934G" title="DOI URL">https://doi.org/10.1039/C8RA01934G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA01934G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA01934G%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DLatest%252Bperspectives%252Bof%252Borally%252Bbioavailable%252B2%25252C4-diarylaminopyrimidine%252Banalogues%252B%252528DAAPalogues%252529%252Bas%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitors%25253A%252Bdiscovery%252Band%252Bclinical%252Bdevelopments%26aulast%3DLatif%26aufirst%3DMuhammad%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D30%26spage%3D16470%26epage%3D16493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Hatcher</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitors of ALK. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 435-467. <a href="https://doi.org/10.1007/7355_2017_18" title="DOI URL">https://doi.org/10.1007/7355_2017_18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2017_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2017_18%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BMolecule%252BInhibitors%252Bof%252BALK%26aulast%3DHatcher%26aufirst%3DJohn%2BM.%26date%3D2017%26spage%3D435%26epage%3D467%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DCancer%252BII%26aulast%3DWaring%26aufirst%3DMichael%2BJ.%26date%3D2018%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mei  Han</span>, <span class="hlFld-ContribAuthor ">Chengyan  Wang</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Li  Xing</span>, <span class="hlFld-ContribAuthor ">Yi  Su</span>, <span class="hlFld-ContribAuthor ">Xisheng  Wang</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism-based structure optimization: Discovery of a potent and orally available tyrosine kinase ALK inhibitor bearing the tetracyclic benzo[b]carbazolone core. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (22)
                                     , 5399-5402. <a href="https://doi.org/10.1016/j.bmcl.2016.10.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMetabolism-based%252Bstructure%252Boptimization%25253A%252BDiscovery%252Bof%252Ba%252Bpotent%252Band%252Borally%252Bavailable%252Btyrosine%252Bkinase%252BALK%252Binhibitor%252Bbearing%252Bthe%252Btetracyclic%252Bbenzo%25255Bb%25255Dcarbazolone%252Bcore%26aulast%3DHan%26aufirst%3DMei%26date%3D2016%26volume%3D26%26issue%3D22%26spage%3D5399%26epage%3D5402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saikiran Reddy  Peddi</span>, <span class="hlFld-ContribAuthor ">Sree Kanth  Sivan</span>, <span class="hlFld-ContribAuthor ">Vijjulatha  Manga</span>. </span><span class="cited-content_cbyCitation_article-title">An integrated molecular modeling approach for
              in silico
              design of new tetracyclic derivatives as ALK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2016,</strong> <em>36 </em>
                                    (5)
                                     , 488-504. <a href="https://doi.org/10.3109/10799893.2015.1130057" title="DOI URL">https://doi.org/10.3109/10799893.2015.1130057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/10799893.2015.1130057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F10799893.2015.1130057%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DAn%252Bintegrated%252Bmolecular%252Bmodeling%252Bapproach%252Bfor%252Bin%252Bsilico%252Bdesign%252Bof%252Bnew%252Btetracyclic%252Bderivatives%252Bas%252BALK%252Binhibitors%26aulast%3DPeddi%26aufirst%3DSaikiran%2BReddy%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D5%26spage%3D488%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio  Rossi</span>. </span><span class="cited-content_cbyCitation_article-title">Alectinib for ALK-positive non-small-cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2016,</strong> <em>9 </em>
                                    (8)
                                     , 1005-1013. <a href="https://doi.org/10.1080/17512433.2016.1195262" title="DOI URL">https://doi.org/10.1080/17512433.2016.1195262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17512433.2016.1195262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17512433.2016.1195262%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DAlectinib%252Bfor%252BALK-positive%252Bnon-small-cell%252Blung%252Bcancer%26aulast%3DRossi%26aufirst%3DAntonio%26date%3D2016%26date%3D2016%26volume%3D9%26issue%3D8%26spage%3D1005%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Zongjun  Xia</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Li  Xing</span>, <span class="hlFld-ContribAuthor ">Yinglei  Gao</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>118 </em>, 244-249. <a href="https://doi.org/10.1016/j.ejmech.2016.04.046" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.04.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.04.046%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAn%252Borally%252Bavailable%252Btyrosine%252Bkinase%252BALK%252Band%252BRET%252Bdual%252Binhibitor%252Bbearing%252Bthe%252Btetracyclic%252Bbenzo%25255Bb%25255Dcarbazolone%252Bcore%26aulast%3DSong%26aufirst%3DZilan%26date%3D2016%26volume%3D118%26spage%3D244%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Fischer Indole Synthesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 41-115. <a href="https://doi.org/10.1002/9781118695692.ch2" title="DOI URL">https://doi.org/10.1002/9781118695692.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118695692.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118695692.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DFischer%252BIndole%252BSynthesis%26date%3D2016%26date%3D2016%26spage%3D41%26epage%3D115%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DIndole%252BRing%252BSynthesis%26aulast%3DGribble%26aufirst%3DGordon%2BW.%26date%3D2016%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew C.  Flick</span>, <span class="hlFld-ContribAuthor ">Hong X.  Ding</span>, <span class="hlFld-ContribAuthor ">Carolyn A.  Leverett</span>, <span class="hlFld-ContribAuthor ">Robert E.  Kyne</span>, <span class="hlFld-ContribAuthor ">Kevin K.-C.  Liu</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Fink</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches to the 2014 new drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (9)
                                     , 1937-1980. <a href="https://doi.org/10.1016/j.bmc.2016.03.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Bto%252Bthe%252B2014%252Bnew%252Bdrugs%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2016%26volume%3D24%26issue%3D9%26spage%3D1937%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>, <span class="hlFld-ContribAuthor ">Bei  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Jiang</span>, <span class="hlFld-ContribAuthor ">Yunho  Jin</span>, <span class="hlFld-ContribAuthor ">Wenshuo  Lu</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Marsilje</span>, <span class="hlFld-ContribAuthor ">Wei  Pei</span>, <span class="hlFld-ContribAuthor ">Tetsuo  Uno</span>, <span class="hlFld-ContribAuthor ">Xuefeng  Zhu</span>, <span class="hlFld-ContribAuthor ">Baogen  Wu</span>, <span class="hlFld-ContribAuthor ">Truc Ngoc  Nguyen</span>, <span class="hlFld-ContribAuthor ">Badry  Bursulaya</span>, <span class="hlFld-ContribAuthor ">Christian  Lee</span>, <span class="hlFld-ContribAuthor ">Nanxin  Li</span>, <span class="hlFld-ContribAuthor ">Sungjoon  Kim</span>, <span class="hlFld-ContribAuthor ">Tove  Tuntland</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Frank  Sun</span>, <span class="hlFld-ContribAuthor ">Auzon  Steffy</span>, <span class="hlFld-ContribAuthor ">Tami  Hood</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (3)
                                     , 1090-1096. <a href="https://doi.org/10.1016/j.bmcl.2015.11.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnovel%252Bselective%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitors%26aulast%3DMichellys%26aufirst%3DPierre-Yves%26date%3D2016%26volume%3D26%26issue%3D3%26spage%3D1090%26epage%3D1096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolong  Jiang</span>, <span class="hlFld-ContribAuthor ">Ji  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Li  Xing</span>, <span class="hlFld-ContribAuthor ">Yong  Xi</span>, <span class="hlFld-ContribAuthor ">Junfeng  Guo</span>, <span class="hlFld-ContribAuthor ">Qizheng  Yao</span>, <span class="hlFld-ContribAuthor ">Jian  Ding</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure—activity relationship study. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>105 </em>, 39-56. <a href="https://doi.org/10.1016/j.ejmech.2015.10.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Btetracyclic%252Bbenzo%25255Bb%25255Dcarbazolones%252Bas%252Bhighly%252Bpotent%252Band%252Borally%252Bbioavailable%252BALK%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bstructure%2525E2%252580%252594activity%252Brelationship%252Bstudy%26aulast%3DJiang%26aufirst%3DXiaolong%26date%3D2015%26volume%3D105%26spage%3D39%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peilong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiaqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Boyu  Zhong</span>, <span class="hlFld-ContribAuthor ">Deyi  Zhang</span>, <span class="hlFld-ContribAuthor ">Can  Jin</span>, <span class="hlFld-ContribAuthor ">Xuejing  Meng</span>, <span class="hlFld-ContribAuthor ">Desheng  Sun</span>, <span class="hlFld-ContribAuthor ">Xiangyuan  Xu</span>, <span class="hlFld-ContribAuthor ">Yong  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhi  Liang</span>, <span class="hlFld-ContribAuthor ">Minghua  Ji</span>, <span class="hlFld-ContribAuthor ">Hailong  Li</span>, <span class="hlFld-ContribAuthor ">Tao  Xu</span>, <span class="hlFld-ContribAuthor ">Guowei  Song</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Hongbin  Yuan</span>, <span class="hlFld-ContribAuthor ">Joe  Shih</span>, <span class="hlFld-ContribAuthor ">Ruihao  Zhang</span>, <span class="hlFld-ContribAuthor ">Guojun  Hou</span>, <span class="hlFld-ContribAuthor ">Ying  Jin</span>, <span class="hlFld-ContribAuthor ">Qiong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-arylamino-4-(1-methyl-3-isopropylsulfonyl-4-pyrazol-amino)pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (17)
                                     , 3738-3743. <a href="https://doi.org/10.1016/j.bmcl.2015.06.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.06.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.06.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-arylamino-4-%2525281-methyl-3-isopropylsulfonyl-4-pyrazol-amino%252529pyrimidines%252Bas%252Bpotent%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitors%26aulast%3DZhang%26aufirst%3DPeilong%26date%3D2015%26volume%3D25%26issue%3D17%26spage%3D3738%26epage%3D3743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siva Senthil Kumar  Boominathan</span>, <span class="hlFld-ContribAuthor ">Gopal Chandru  Senadi</span>, <span class="hlFld-ContribAuthor ">Jaya Kishore  Vandavasi</span>, <span class="hlFld-ContribAuthor ">Jeff Yi‐Fu  Chen</span>, <span class="hlFld-ContribAuthor ">Jeh‐Jeng  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">An Iron‐Catalyzed Cascade Approach to Benzo[
              b
              ]carbazole Synthesis Followed by 1,4‐Sulfonyl Migration. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2015,</strong> <em>21 </em>
                                    (8)
                                     , 3193-3197. <a href="https://doi.org/10.1002/chem.201405695" title="DOI URL">https://doi.org/10.1002/chem.201405695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201405695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201405695%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DAn%252BIron%2525E2%252580%252590Catalyzed%252BCascade%252BApproach%252Bto%252BBenzo%25255B%252Bb%252B%25255Dcarbazole%252BSynthesis%252BFollowed%252Bby%252B1%25252C4%2525E2%252580%252590Sulfonyl%252BMigration%26aulast%3DBoominathan%26aufirst%3DSiva%2BSenthil%2BKumar%26date%3D2015%26date%3D2015%26volume%3D21%26issue%3D8%26spage%3D3193%26epage%3D3197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoping  Zhang</span>, <span class="hlFld-ContribAuthor ">Kezhi  Jiang</span>, <span class="hlFld-ContribAuthor ">Jingfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Zuguang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Two competing ionization processes in electrospray mass spectrometry of indolyl benzo[
              b
              ]carbazoles: formation of M
              +•
              versus [M + H]
              +. </span><span class="cited-content_cbyCitation_journal-name">Rapid Communications in Mass Spectrometry</span><span> <strong>2015,</strong> <em>29 </em>
                                    (3)
                                     , 263-268. <a href="https://doi.org/10.1002/rcm.7103" title="DOI URL">https://doi.org/10.1002/rcm.7103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/rcm.7103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Frcm.7103%26sid%3Dliteratum%253Aachs%26jtitle%3DRapid%2520Communications%2520in%2520Mass%2520Spectrometry%26atitle%3DTwo%252Bcompeting%252Bionization%252Bprocesses%252Bin%252Belectrospray%252Bmass%252Bspectrometry%252Bof%252Bindolyl%252Bbenzo%25255B%252Bb%252B%25255Dcarbazoles%25253A%252Bformation%252Bof%252BM%252B%25252B%2525E2%252580%2525A2%252Bversus%252B%25255BM%2525E2%252580%252589%25252B%2525E2%252580%252589H%25255D%252B%25252B%26aulast%3DZhang%26aufirst%3DXiaoping%26date%3D2015%26date%3D2014%26volume%3D29%26issue%3D3%26spage%3D263%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Meining  Wang</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     , 34-37. <a href="https://doi.org/10.1016/j.apsb.2014.12.007" title="DOI URL">https://doi.org/10.1016/j.apsb.2014.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2014.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2014.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DAlectinib%25253A%252Ba%252Bnovel%252Bsecond%252Bgeneration%252Banaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitor%252Bfor%252Bovercoming%252Bclinically-acquired%252Bresistance%26aulast%3DSong%26aufirst%3DZilan%26date%3D2015%26volume%3D5%26issue%3D1%26spage%3D34%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">James A.  Bull</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Di-, Tri-, and Tetrasubstituted Oxetanes by Rhodium-Catalyzed OH Insertion and CC Bond-Forming Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (51)
                                     , 14454-14458. <a href="https://doi.org/10.1002/ange.201408928" title="DOI URL">https://doi.org/10.1002/ange.201408928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201408928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201408928%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSynthesis%252Bof%252BDi-%25252C%252BTri-%25252C%252Band%252BTetrasubstituted%252BOxetanes%252Bby%252BRhodium-Catalyzed%252BO%2525EF%2525A3%2525BFH%252BInsertion%252Band%252BC%2525EF%2525A3%2525BFC%252BBond-Forming%252BCyclization%26aulast%3DDavis%26aufirst%3DOwen%2BA.%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D51%26spage%3D14454%26epage%3D14458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Owen A.  Davis</span>, <span class="hlFld-ContribAuthor ">James A.  Bull</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Di-, Tri-, and Tetrasubstituted Oxetanes by Rhodium-Catalyzed OH Insertion and CC Bond-Forming Cyclization. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (51)
                                     , 14230-14234. <a href="https://doi.org/10.1002/anie.201408928" title="DOI URL">https://doi.org/10.1002/anie.201408928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201408928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201408928%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSynthesis%252Bof%252BDi-%25252C%252BTri-%25252C%252Band%252BTetrasubstituted%252BOxetanes%252Bby%252BRhodium-Catalyzed%252BO%2525EF%2525A3%2525BFH%252BInsertion%252Band%252BC%2525EF%2525A3%2525BFC%252BBond-Forming%252BCyclization%26aulast%3DDavis%26aufirst%3DOwen%2BA.%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D51%26spage%3D14230%26epage%3D14234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugen F  Mesaros</span>, <span class="hlFld-ContribAuthor ">Gregory R  Ott</span>, <span class="hlFld-ContribAuthor ">Bruce D  Dorsey</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (4)
                                     , 417-442. <a href="https://doi.org/10.1517/13543776.2014.877890" title="DOI URL">https://doi.org/10.1517/13543776.2014.877890</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.877890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.877890%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAnaplastic%252Blymphoma%252Bkinase%252Binhibitors%252Bas%252Banticancer%252Btherapeutics%25253A%252Ba%252Bpatent%252Breview%26aulast%3DMesaros%26aufirst%3DEugen%2BF%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D417%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anisley  Suárez</span>, <span class="hlFld-ContribAuthor ">Patricia  García-García</span>, <span class="hlFld-ContribAuthor ">Manuel A.  Fernández-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Roberto  Sanz</span>. </span><span class="cited-content_cbyCitation_article-title">Brønsted Acid-Catalyzed Straightforward Synthesis of Benzo[
              b
              ]carbazoles from 2,3-Unsubstituted Indoles. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2014,</strong> <em>356 </em>
                                    (2-3)
                                     , 374-382. <a href="https://doi.org/10.1002/adsc.201300868" title="DOI URL">https://doi.org/10.1002/adsc.201300868</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201300868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201300868%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DBr%2525C3%2525B8nsted%252BAcid-Catalyzed%252BStraightforward%252BSynthesis%252Bof%252BBenzo%25255B%252Bb%252B%25255Dcarbazoles%252Bfrom%252B2%25252C3-Unsubstituted%252BIndoles%26aulast%3DSu%25C3%25A1rez%26aufirst%3DAnisley%26date%3D2014%26date%3D2014%26volume%3D356%26issue%3D2-3%26spage%3D374%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Chieh  Wang</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Shiao</span>, <span class="hlFld-ContribAuthor ">Chieh-Chien  Lee</span>, <span class="hlFld-ContribAuthor ">Ka-Shu  Fung</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (9)
                                     , 1266-1279. <a href="https://doi.org/10.1039/C4MD00048J" title="DOI URL">https://doi.org/10.1039/C4MD00048J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00048J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00048J%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DAnaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Bdesign%252Band%252Bdiscovery%26aulast%3DWang%26aufirst%3DWen-Chieh%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D9%26spage%3D1266%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin-Feng  Zou</span>, <span class="hlFld-ContribAuthor ">Hu  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Zheng  Xu</span>, <span class="hlFld-ContribAuthor ">Ke-Fang  Yang</span>, <span class="hlFld-ContribAuthor ">Li-Wen  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Fe-catalyzed cycloaddition of indoles and o-phthalaldehyde for the synthesis of benzo[b]carbazoles with TMSCl- or acid-responsive properties. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (88)
                                     , 47272-47277. <a href="https://doi.org/10.1039/C4RA08012B" title="DOI URL">https://doi.org/10.1039/C4RA08012B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA08012B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA08012B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DFe-catalyzed%252Bcycloaddition%252Bof%252Bindoles%252Band%252Bo-phthalaldehyde%252Bfor%252Bthe%252Bsynthesis%252Bof%252Bbenzo%25255Bb%25255Dcarbazoles%252Bwith%252BTMSCl-%252Bor%252Bacid-responsive%252Bproperties%26aulast%3DZou%26aufirst%3DJin-Feng%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D88%26spage%3D47272%26epage%3D47277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Latif</span>, <span class="hlFld-ContribAuthor ">Aamer  Saeed</span>, <span class="hlFld-ContribAuthor ">Seong Hwan  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Journey of the ALK-inhibitor CH5424802 to phase II clinical trial. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2013,</strong> <em>36 </em>
                                    (9)
                                     , 1051-1054. <a href="https://doi.org/10.1007/s12272-013-0157-8" title="DOI URL">https://doi.org/10.1007/s12272-013-0157-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-013-0157-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-013-0157-8%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DJourney%252Bof%252Bthe%252BALK-inhibitor%252BCH5424802%252Bto%252Bphase%252BII%252Bclinical%252Btrial%26aulast%3DLatif%26aufirst%3DMuhammad%26date%3D2013%26date%3D2013%26volume%3D36%26issue%3D9%26spage%3D1051%26epage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mostafa  Kiamehr</span>, <span class="hlFld-ContribAuthor ">Firouz Matloubi  Moghaddam</span>, <span class="hlFld-ContribAuthor ">Volodymyr  Semeniuchenko</span>, <span class="hlFld-ContribAuthor ">Alexander  Villinger</span>, <span class="hlFld-ContribAuthor ">Peter  Langer</span>, <span class="hlFld-ContribAuthor ">Viktor O.  Iaroshenko</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of thiochromeno[2,3-b]indol-11(6H)-ones and pyrido[3′,2′:5,6]thiopyrano[2,3-b]indol-5(10H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2013,</strong> <em>54 </em>
                                    (37)
                                     , 5018-5021. <a href="https://doi.org/10.1016/j.tetlet.2013.07.012" title="DOI URL">https://doi.org/10.1016/j.tetlet.2013.07.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2013.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2013.07.012%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252Bthiochromeno%25255B2%25252C3-b%25255Dindol-11%2525286H%252529-ones%252Band%252Bpyrido%25255B3%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A5%25252C6%25255Dthiopyrano%25255B2%25252C3-b%25255Dindol-5%25252810H%252529-ones%26aulast%3DKiamehr%26aufirst%3DMostafa%26date%3D2013%26volume%3D54%26issue%3D37%26spage%3D5018%26epage%3D5021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic lymphoma kinase (ALK): Structure, oncogenic activation, and pharmacological inhibition. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2013,</strong> <em>68 </em>
                                    (1)
                                     , 68-94. <a href="https://doi.org/10.1016/j.phrs.2012.11.007" title="DOI URL">https://doi.org/10.1016/j.phrs.2012.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2012.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2012.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DAnaplastic%252Blymphoma%252Bkinase%252B%252528ALK%252529%25253A%252BStructure%25252C%252Boncogenic%252Bactivation%25252C%252Band%252Bpharmacological%252Binhibition%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2013%26volume%3D68%26issue%3D1%26spage%3D68%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bucong  Han</span>, <span class="hlFld-ContribAuthor ">Xiaohua  Ma</span>, <span class="hlFld-ContribAuthor ">Ruiying  Zhao</span>, <span class="hlFld-ContribAuthor ">Jingxian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaona  Wei</span>, <span class="hlFld-ContribAuthor ">Xianghui  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Cunlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Chunyan  Tan</span>, <span class="hlFld-ContribAuthor ">Yuyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Yuzong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Development and experimental test of support vector machines virtual screening method for searching Src inhibitors from large compound libraries. </span><span class="cited-content_cbyCitation_journal-name">Chemistry Central Journal</span><span> <strong>2012,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/1752-153X-6-139" title="DOI URL">https://doi.org/10.1186/1752-153X-6-139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1752-153X-6-139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1752-153X-6-139%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520Central%2520Journal%26atitle%3DDevelopment%252Band%252Bexperimental%252Btest%252Bof%252Bsupport%252Bvector%252Bmachines%252Bvirtual%252Bscreening%252Bmethod%252Bfor%252Bsearching%252BSrc%252Binhibitors%252Bfrom%252Blarge%252Bcompound%252Blibraries%26aulast%3DHan%26aufirst%3DBucong%26date%3D2012%26date%3D2012%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linda F.  Epstein</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Renee  Emkey</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>. </span><span class="cited-content_cbyCitation_article-title">The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2012,</strong> <em>287 </em>
                                    (44)
                                     , 37447-37457. <a href="https://doi.org/10.1074/jbc.M112.391425" title="DOI URL">https://doi.org/10.1074/jbc.M112.391425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M112.391425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M112.391425%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DThe%252BR1275Q%252BNeuroblastoma%252BMutant%252Band%252BCertain%252BATP-competitive%252BInhibitors%252BStabilize%252BAlternative%252BActivation%252BLoop%252BConformations%252Bof%252BAnaplastic%252BLymphoma%252BKinase%26aulast%3DEpstein%26aufirst%3DLinda%2BF.%26date%3D2012%26volume%3D287%26issue%3D44%26spage%3D37447%26epage%3D37457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazutomo  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Kohsuke  Asoh</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Furuichi</span>, <span class="hlFld-ContribAuthor ">Toshiya  Ito</span>, <span class="hlFld-ContribAuthor ">Hatsuo  Kawada</span>, <span class="hlFld-ContribAuthor ">Sousuke  Hara</span>, <span class="hlFld-ContribAuthor ">Jun  Ohwada</span>, <span class="hlFld-ContribAuthor ">Takuho  Miyagi</span>, <span class="hlFld-ContribAuthor ">Takamitsu  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Kenji  Takanashi</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Tsukaguchi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Takuo  Tsukuda</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Oikawa</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (3)
                                     , 1271-1280. <a href="https://doi.org/10.1016/j.bmc.2011.12.021" title="DOI URL">https://doi.org/10.1016/j.bmc.2011.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2011.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2011.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Ba%252Bhighly%252Bselective%25252C%252Borally%252Bactive%252Band%252Bpotent%252Banaplastic%252Blymphoma%252Bkinase%252Binhibitor%252B%252528CH5424802%252529%26aulast%3DKinoshita%26aufirst%3DKazutomo%26date%3D2012%26volume%3D20%26issue%3D3%26spage%3D1271%26epage%3D1280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benito  Alcaide</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 115-137. <a href="https://doi.org/10.1016/B978-0-08-096807-0.00004-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-096807-0.00004-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096807-0.00004-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096807-0.00004-X%26sid%3Dliteratum%253Aachs%26atitle%3DFour-Membered%252BRing%252BSystems%26aulast%3DAlcaide%26aufirst%3DBenito%26date%3D2012%26spage%3D115%26epage%3D137%26pub%3DElsevier%26date%3D2012%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazutomo  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Oikawa</span>, <span class="hlFld-ContribAuthor ">Takuo  Tsukuda</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 281-293. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00019-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00019-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00019-9%26sid%3Dliteratum%253Aachs%26atitle%3DAnaplastic%252BLymphoma%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BALK-Positive%252BCancers%26aulast%3DKinoshita%26aufirst%3DKazutomo%26date%3D2012%26spage%3D281%26epage%3D293%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of ALK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compound <b>13a</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-Boc-piperazine, NMP, 140 °C; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 3-oxetanone, NaBH(OAc)<sub>3</sub>, THF, 40 °C.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>13b</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-bromosuccinimide, CH<sub>3</sub>CN, rt; (b) 3-cyanophenylhydrazine, TFA, 100 °C; (c) DDQ, THF/H<sub>2</sub>O, 0 °C; (d) pyridinium hydrochloride, 190 °C; (e) trifluoromethanesulfonic anhydride, pyridine, rt; (f) piperazine, NMP, 120 °C; (g) 3-oxetanone, NaBH<sub>3</sub>CN, AcOH, THF/MeOH, rt; (h) trimethylboroxine, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, 100 °C; (i) TIPS-acetylene, Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C, and then TBAF, THF, rt; (j) propyne, Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C; (k) isopropenylboronic acid pinacol ester, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 80 °C; (l) cyclopentylacetylene, Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 80 °C; (m) 10% Pd/C, H<sub>2</sub> gas, THF/MeOH, rt.</p></p></figure><figure data-id="cht1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Amino Acid Sequences of ALK and Off-Target Proteins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding model of <b>13a</b> in complex with human ALK derived from the X-ray cocrystal structure with <b>14</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AOX">3AOX</a>). Compound <b>13a</b> is shown as a stick model colored by element type (C in green, O in red, and N in blue). Overall structure of human ALK is shown as a cartoon diagram in pale blue. Residues L<sub>1198</sub> through G<sub>1202</sub> of human ALK are shown as a stick model colored by element type as the ligand except C in white and S in yellow. A hydrogen bond between the carbonyl oxygen of <b>13a</b> and the backbone amide of M<sub>1199</sub> (hinge) is depicted by a yellow dashed line. Hydrogen atoms and solvent molecules are not displayed for clarity. The distance between C9 and alfa carbon of A<sub>1200</sub> is 4.2 Å. The figure was prepared with PyMol (<a href="http://www.pymol.org" class="extLink">http://www.pymol.org</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/medium/jm-2011-00652u_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Growth inhibitory effect of <b>13d</b> on KARPAS-299 tumor growth in mouse xenograft model. SCID mice bearing KARPAS-299 were administered compound <b>13d</b> orally once daily for 11 d (days 8–18) at 2 mg/kg (tumor growth inhibition TGI = 49%), 6 mg/kg (TGI = 103%), and 20 mg/kg (TGI = 119%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-18/jm200652u/production/images/large/jm-2011-00652u_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200652u&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naeve, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathew, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, D. P.</span><span> </span><span class="NLM_article-title"><i>ALK</i>, The Chromosome 2 Gene Locus Altered by the t(2;5) in Non-Hodgkin’s Lymphoma, Encodes a Novel Neural Receptor Tyrosine Kinase That Is Highly Related to Leukocyte Tyrosine Kinase (LTK)</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2175</span><span class="NLM_x">–</span> <span class="NLM_lpage">2188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1997&pages=2175-2188&author=S.+W.+Morrisauthor=C.+Naeveauthor=P.+Mathewauthor=P.+L.+Jamesauthor=M.+N.+Kirsteinauthor=X.+Cuiauthor=D.+P.+Witte&title=ALK%2C+The+Chromosome+2+Gene+Locus+Altered+by+the+t%282%3B5%29+in+Non-Hodgkin%E2%80%99s+Lymphoma%2C+Encodes+a+Novel+Neural+Receptor+Tyrosine+Kinase+That+Is+Highly+Related+to+Leukocyte+Tyrosine+Kinase+%28LTK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DNaeve%26aufirst%3DC.%26aulast%3DMathew%26aufirst%3DP.%26aulast%3DJames%26aufirst%3DP.%2BL.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DWitte%26aufirst%3DD.%2BP.%26atitle%3DALK%252C%2520The%2520Chromosome%25202%2520Gene%2520Locus%2520Altered%2520by%2520the%2520t%25282%253B5%2529%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%252C%2520Encodes%2520a%2520Novel%2520Neural%2520Receptor%2520Tyrosine%2520Kinase%2520That%2520Is%2520Highly%2520Related%2520to%2520Leukocyte%2520Tyrosine%2520Kinase%2520%2528LTK%2529%26jtitle%3DOncogene%26date%3D1997%26volume%3D14%26spage%3D2175%26epage%3D2188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pulford, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delsol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, D. Y.</span><span> </span><span class="NLM_article-title">Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells with the Monoclonal Antibody ALK1</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1394</span><span class="NLM_x">–</span> <span class="NLM_lpage">1404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1997&pages=1394-1404&author=K.+Pulfordauthor=L.+Lamantauthor=S.+W.+Morrisauthor=L.+H.+Butlerauthor=K.+M.+Woodauthor=D.+Stroudauthor=G.+Delsolauthor=D.+Y.+Mason&title=Detection+of+Anaplastic+Lymphoma+Kinase+%28ALK%29+and+Nucleolar+Protein+Nucleophosmin+%28NPM%29-ALK+Proteins+in+Normal+and+Neoplastic+Cells+with+the+Monoclonal+Antibody+ALK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPulford%26aufirst%3DK.%26aulast%3DLamant%26aufirst%3DL.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DButler%26aufirst%3DL.%2BH.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DStroud%26aufirst%3DD.%26aulast%3DDelsol%26aufirst%3DG.%26aulast%3DMason%26aufirst%3DD.%2BY.%26atitle%3DDetection%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%2520and%2520Nucleolar%2520Protein%2520Nucleophosmin%2520%2528NPM%2529-ALK%2520Proteins%2520in%2520Normal%2520and%2520Neoplastic%2520Cells%2520with%2520the%2520Monoclonal%2520Antibody%2520ALK1%26jtitle%3DBlood%26date%3D1997%26volume%3D89%26spage%3D1394%26epage%3D1404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin’s Lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+Kinase+Gene%2C+ALK%2C+to+a+Nucleolar+Protein+Gene%2C+NPM%2C+in+Non-Hodgkin%E2%80%99s+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520Kinase%2520Gene%252C%2520ALK%252C%2520to%2520a%2520Nucleolar%2520Protein%2520Gene%252C%2520NPM%252C%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Li, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span> </span><span class="NLM_article-title">Development of Anaplastic Lymphoma Kinase (ALK) Small-Molecule Inhibitors for Cancer Therapy</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1002%2Fmed.20109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17694547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVyltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=372-412&author=R.+Liauthor=S.+W.+Morris&title=Development+of+Anaplastic+Lymphoma+Kinase+%28ALK%29+Small-Molecule+Inhibitors+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy</span></div><div class="casAuthors">Li, Rongshi; Morris, Stephan W.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-412</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fusion forms-the most common being nucleophosmin (NPM)-ALK-in a nonHodgkin's lymphoma (NHL) known as anaplastic large-cell lymphoma (ALCL) and subsequent studies identified ALK fusions in the human sarcomas called inflammatory myofibroblastic tumors (IMTs).  In addn., two recent reports have suggested that the ALK fusion, TPM4-ALK, may be involved in the genesis of a subset of esophageal squamous cell carcinomas.  While the cause-effect relationship between ALK fusions and malignancies such as ALCL and IMT is very well established, more circumstantial links implicate the involvement of the full-length, normal ALK receptor in the genesis of addnl. malignancies including glioblastoma, neuroblastoma, breast cancer, and others; in these instances, ALK is believed to foster tumorigenesis following activation by autocrine and/or paracrine growth loops involving the reported ALK ligands, pleiotrophin (PTN) and midkine (MK).  There are no currently available ALK small-mol. inhibitors approved for clin. cancer therapy; however, recognition of the variety of malignancies in which ALK may play a causative role has recently begun to prompt developmental efforts in this area.  This review provides a succinct summary of normal ALK biol., the confirmed and putative roles of ALK fusions and the full-length ALK receptor in the development of human cancers, and efforts to target ALK using small-mol. kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB3B7c_OpT2LVg90H21EOLACvtfcHk0ljwQ-cEIRSs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVyltLs%253D&md5=d8521d00232b6b3d1c807fb65645ac67</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fmed.20109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20109%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26atitle%3DDevelopment%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%2520Small-Molecule%2520Inhibitors%2520for%2520Cancer%2520Therapy%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D372%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slavish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rentrop, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span> </span><span class="NLM_article-title">Anaplastic Lymphoma Kinase: Role in Cancer Pathogenesis and Small-Molecule Inhibitor Development for Therapy</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1586%2F14737140.9.3.331" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19275511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=331-356&author=T.+R.+Webbauthor=J.+Slavishauthor=R.+E.+Georgeauthor=A.+T.+Lookauthor=L.+Xueauthor=Q.+Jiangauthor=X.+Cuiauthor=W.+B.+Rentropauthor=S.+W.+Morris&title=Anaplastic+Lymphoma+Kinase%3A+Role+in+Cancer+Pathogenesis+and+Small-Molecule+Inhibitor+Development+for+Therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy</span></div><div class="casAuthors">Webb, Thomas R.; Slavish, Jake; George, Rani E.; Look, A. Thomas; Xue, Liquan; Jiang, Qin; Cui, Xiaoli; Rentrop, Walter B.; Morris, Stephan W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-356</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase in the insulin receptor superfamily, was initially identified in constitutively activated oncogenic fusion forms - the most common being nucleophosmin-ALK - in anaplastic large-cell lymphomas, and subsequent studies have identified ALK fusions in diffuse large B-cell lymphomas, systemic histiocytosis, inflammatory myofibroblastic tumors, esophageal squamous cell carcinomas and non-small-cell lung carcinomas.  More recently, genomic DNA amplification and protein overexpression, as well as activating point mutations, of ALK have been described in neuroblastomas.  In addn. to those cancers for which a causative role for aberrant ALK activity is well validated, more circumstantial links implicate the full-length, normal ALK receptor in the genesis of other malignancies - including glioblastoma and breast cancer - via a mechanism of receptor activation involving autocrine and/or paracrine growth loops with the reported ALK ligands, pleiotrophin and midkine.  This review summarizes normal ALK biol., the confirmed and putative roles of ALK in the development of human cancers and efforts to target ALK using small-mol. kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoERzbvlik_c7Vg90H21EOLACvtfcHk0ljwQ-cEIRSs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFaltrc%253D&md5=a980ef18ac316bd3894b72ddd2748c17</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1586%2F14737140.9.3.331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737140.9.3.331%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DSlavish%26aufirst%3DJ.%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DLook%26aufirst%3DA.%2BT.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DRentrop%26aufirst%3DW.%2BB.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26atitle%3DAnaplastic%2520Lymphoma%2520Kinase%253A%2520Role%2520in%2520Cancer%2520Pathogenesis%2520and%2520Small-Molecule%2520Inhibitor%2520Development%2520for%2520Therapy%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2009%26volume%3D9%26spage%3D331%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Griffin, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingham, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlman, E. J.</span><span> </span><span class="NLM_article-title">Recurrent Involvement of 2p23 in Inflammatory Myofibroblastic Tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">2776</span><span class="NLM_x">–</span> <span class="NLM_lpage">2780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=10383129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=2776-2780&author=C.+A.+Griffinauthor=A.+L.+Hawkinsauthor=C.+Dvorakauthor=C.+Henkleauthor=T.+Ellinghamauthor=E.+J.+Perlman&title=Recurrent+Involvement+of+2p23+in+Inflammatory+Myofibroblastic+Tumors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors</span></div><div class="casAuthors">Griffin, Constance A.; Hawkins, Anita L.; Dvorak, Cecily; Henkle, Carol; Ellingham, Tara; Perlman, Elizabeth J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2776-2780</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Inflammatory myofibroblastic tumor (IMT) is a relatively rare soft tissue tumor.  The reactive vs. neoplastic pathogenesis of this tumor is unresolved.  We found clonal chromosome aberrations involving 2p23 upon metaphase anal. of two IMTs.  Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated rearrangement of the probe in both of these cases and in a third case, and immunohistochem. revealed ALK expression in all three cases.  A 2p22-24 involvement has been reported previously in four addnl. cases of IMT.  We suggest that chromosomal rearrangements involving 2p23 near or within ALK are recurrent alterations in IMT and that ALK may have a novel role outside its previously recognized realm of lymphoid neoplasms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocvXV2ukz3crVg90H21EOLACvtfcHk0ljwQ-cEIRSs2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVOktbk%253D&md5=8054eeaaf0cb85ee85afff461797c84c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DC.%2BA.%26aulast%3DHawkins%26aufirst%3DA.%2BL.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DHenkle%26aufirst%3DC.%26aulast%3DEllingham%26aufirst%3DT.%26aulast%3DPerlman%26aufirst%3DE.%2BJ.%26atitle%3DRecurrent%2520Involvement%2520of%25202p23%2520in%2520Inflammatory%2520Myofibroblastic%2520Tumors%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D2776%26epage%3D2780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gascoyne, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamant, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Subero, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lestou, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller-Hermelink, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horsman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auvigne, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delsol, G.</span><span> </span><span class="NLM_article-title">ALK-Positive Diffuse Large B-cell Lymphoma is Associated with <i>Clathrin-ALK</i> Rearrangements: Report of 6 Cases</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">2568</span><span class="NLM_x">–</span> <span class="NLM_lpage">2573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1182%2Fblood-2003-03-0786" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=12763927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=2568-2573&author=R.+D.+Gascoyneauthor=L.+Lamantauthor=J.+I.+Martin-Suberoauthor=V.+S.+Lestouauthor=N.+L.+Harrisauthor=H.+K.+Muller-Hermelinkauthor=J.+F.+Seymourauthor=L.+J.+Campbellauthor=D.+E.+Horsmanauthor=I.+Auvigneauthor=E.+Espinosauthor=R.+Siebertauthor=G.+Delsol&title=ALK-Positive+Diffuse+Large+B-cell+Lymphoma+is+Associated+with+Clathrin-ALK+Rearrangements%3A+Report+of+6+Cases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">ALK-positive diffuse large B-cell lymphoma is associated with clathrin-ALK rearrangements: Report of 6 cases</span></div><div class="casAuthors">Gascoyne, Randy D.; Lamant, Laurence; Martin-Subero, Jose I.; Lestou, Valia S.; Harris, Nancy Lee; Mueller-Hermelink, Hans-Konrad; Seymour, John F.; Campbell, Lynda J.; Horsman, Douglas E.; Auvigne, Isabelle; Espinos, Estelle; Siebert, Reiner; Delsol, Georges</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2568-2573</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Expression of ALK protein by lymphoid cells and the description of variant anaplastic lymphoma kinase (ALK) translocations have typically been restricted to cases of T-cell and null anaplastic large-cell lymphoma (ALCL).  All such cases result from a novel fusion created by the ALK gene on chromosome 2p23 and NPM on 5q35 or other variant translocation partners.  A rare variant of diffuse large B-cell lymphoma (DLBCL), originally described in 1997, was thought to overexpress full-length ALK in contrast to a chimeric protein characteristic of ALCL.  However, full-length ALK protein lacks tyrosine kinase activity and thus the mechanism of oncogenesis has remained elusive.  We describe 6 cases of ALK+ DLBCL characterized by a simple or complex t(2;17)(p23;q23) involving the clathrin gene (CLTC) at chromosome band 17q23 and the ALK gene at chromosome band 2p23.  All cases were studied using fluorescence in situ hybridization (FISH), complemented in one case with std. cytogenetic anal., multicolor karyotyping (M-FISH), and reverse transcriptase-polymerase chain reaction.  These results clearly demonstrate that most cases of ALK+ DLBCL share the same mechanism of deregulated ALK expression.  Moreover, these results demonstrate the presence of CLTC-ALK fusions in these tumors and extend the list of diseases assocd. with this genetic abnormality to include classical T-cell or null ALCL, ALK+ DLBCL, and inflammatory myofibroblastic tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3UcmsuahiXLVg90H21EOLACvtfcHk0lhODjMtYWunKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslykurw%253D&md5=9eedc8c22c580dbadee982b4d3da35a8</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-03-0786&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-03-0786%26sid%3Dliteratum%253Aachs%26aulast%3DGascoyne%26aufirst%3DR.%2BD.%26aulast%3DLamant%26aufirst%3DL.%26aulast%3DMartin-Subero%26aufirst%3DJ.%2BI.%26aulast%3DLestou%26aufirst%3DV.%2BS.%26aulast%3DHarris%26aufirst%3DN.%2BL.%26aulast%3DMuller-Hermelink%26aufirst%3DH.%2BK.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DCampbell%26aufirst%3DL.%2BJ.%26aulast%3DHorsman%26aufirst%3DD.%2BE.%26aulast%3DAuvigne%26aufirst%3DI.%26aulast%3DEspinos%26aufirst%3DE.%26aulast%3DSiebert%26aufirst%3DR.%26aulast%3DDelsol%26aufirst%3DG.%26atitle%3DALK-Positive%2520Diffuse%2520Large%2520B-cell%2520Lymphoma%2520is%2520Associated%2520with%2520Clathrin-ALK%2520Rearrangements%253A%2520Report%2520of%25206%2520Cases%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D2568%26epage%3D2573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jazii, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Najafi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekzadeh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conrads, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziaee, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abnet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazdznbod, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karkhane, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salekdeh, G. H.</span><span> </span><span class="NLM_article-title">Identification of Squamous Cell Carcinoma Associated Proteins by Proteomics and Loss of Beta Tropomyosin Expression in Esophageal Cancer</span> <span class="citation_source-journal">World J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">7104</span><span class="NLM_x">–</span> <span class="NLM_lpage">7112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.3748%2Fwjg.v12.i44.7104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17131471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls1GksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=7104-7112&author=F.+R.+Jaziiauthor=Z.+Najafiauthor=R.+Malekzadehauthor=T.+P.+Conradsauthor=A.+A.+Ziaeeauthor=C.+Abnetauthor=M.+Yazdznbodauthor=A.+A.+Karkhaneauthor=G.+H.+Salekdeh&title=Identification+of+Squamous+Cell+Carcinoma+Associated+Proteins+by+Proteomics+and+Loss+of+Beta+Tropomyosin+Expression+in+Esophageal+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer</span></div><div class="casAuthors">Jazii, Ferdous Rastgar; Najafi, Zahra; Malekzadeh, Reza; Conrads, Thomas P.; Ziaee, Abed Ali; Abnet, Christian; Yazdznbod, Mansour; Karkhane, Ali Asghar; Salekdeh, Ghasem H.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">7104-7112</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">To assess the proteome of normal vs. tumor tissue in squamous cell carcinoma of the esophagus (SCCE) in Iranian patients and compare our results with former reports by using proteomics.  Protein was extd. from normal and tumor tissues.  Two dimensional electrophoresis was carried out and spots with differential expression were identified with mass spectrometry.  RNA extn. and RT-PCR along with immunodetection were performed.  Fourteen proteins were found whose expression levels differed in tumor compared to normal tissues.  Mass spectrometric anal. resulted in the identification of β-tropomyosin (TMβ), myosin light chain 2 (and its isoform), myosin regulatory light chain 2, peroxyredoxin 2, annexin I and an unknown polypeptide as the down regulated polypeptides in tumor tissue.  Heat shock protein 70 (HSP70), TPM4-ALK fusion oncoprotein 2, myosin light polypeptide 6, keratin I, GH16431p and calreticulin were the up-regulated polypeptides found in tumor tissue.  Several of these proteins, such as TMβ, HSP70, annexin I, calreticulin, TPM4-ALK and isoforms of myosins, have been well recognized in tumorigenesis of esophageal or other types of cancers.  The study not only supports the involvement of some of the formerly reported proteins in SCCE but also introduces addnl. proteins found to be lost in SCCE, including TMβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQBiL27ZRH7Vg90H21EOLACvtfcHk0lhODjMtYWunKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls1GksA%253D%253D&md5=2de4e4dc1639b4414afa8ea6e072c22c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v12.i44.7104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v12.i44.7104%26sid%3Dliteratum%253Aachs%26aulast%3DJazii%26aufirst%3DF.%2BR.%26aulast%3DNajafi%26aufirst%3DZ.%26aulast%3DMalekzadeh%26aufirst%3DR.%26aulast%3DConrads%26aufirst%3DT.%2BP.%26aulast%3DZiaee%26aufirst%3DA.%2BA.%26aulast%3DAbnet%26aufirst%3DC.%26aulast%3DYazdznbod%26aufirst%3DM.%26aulast%3DKarkhane%26aufirst%3DA.%2BA.%26aulast%3DSalekdeh%26aufirst%3DG.%2BH.%26atitle%3DIdentification%2520of%2520Squamous%2520Cell%2520Carcinoma%2520Associated%2520Proteins%2520by%2520Proteomics%2520and%2520Loss%2520of%2520Beta%2520Tropomyosin%2520Expression%2520in%2520Esophageal%2520Cancer%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2006%26volume%3D12%26spage%3D7104%26epage%3D7112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the Transforming <i>EML4-ALK</i> Fusion Gene in Non-small-cell Lung Cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1038%2Fnature05945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17625570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+Transforming+EML4-ALK+Fusion+Gene+in+Non-small-cell+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span></div><div class="casAuthors">Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7153</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improvement in the clin. outcome of lung cancer is likely to be achieved by identification of the mol. events that underlie its pathogenesis.  Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-assocd. protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.  Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and s.c. tumors in nude mice.  The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examd.; these individuals were distinct from those harboring mutations in the epidermal growth factor receptor gene.  Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic mol. marker in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhAXuLtrJ6rVg90H21EOLACvtfcHk0lhODjMtYWunKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D&md5=7f567e80814b9ccc87e5bceeebb467a7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnature05945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05945%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520Transforming%2520EML4-ALK%2520Fusion%2520Gene%2520in%2520Non-small-cell%2520Lung%2520Cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Non-solid Oncogenes in Solid Tumors: <i>EML4-ALK</i> Fusion Genes in Lung Cancer</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">2349</span><span class="NLM_x">–</span> <span class="NLM_lpage">2355</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1111%2Fj.1349-7006.2008.00972.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19032370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2008&pages=2349-2355&author=H.+Mano&title=Non-solid+Oncogenes+in+Solid+Tumors%3A+EML4-ALK+Fusion+Genes+in+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer</span></div><div class="casAuthors">Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2349-2355</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  It is generally accepted that recurrent chromosome translocations play a major role in the mol. pathogenesis of hematol. malignancies but not of solid tumors.  However, chromosome translocations involving the e26 transformation-specific sequence transcription factor loci have been demonstrated recently in many prostate cancer cases.  Furthermore, through a functional screening with retroviral cDNA expression libraries, we have discovered the fusion-type protein tyrosine kinase echinoderm microtubule-assocd. protein like-4 (EML4)-anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) specimens.  A recurrent chromosome translocation, inv(2)(p21p23), in NSCLC generates fused mRNA encoding the amino-terminal half of EML4 ligated to the intracellular region of the receptor-type protein tyrosine kinase ALK.  EML4-ALK oligomerizes constitutively in cells through the coiled coil domain within the EML4 region, and becomes activated to exert a marked oncogenicity both in vitro and in vivo.  Break and fusion points within the EML4 locus may diverge in NSCLC cells to generate various isoforms of EML4-ALK, which may constitute -5% of NSCLC cases, at least in the Asian ethnic group.  In the present review I summarize how detection of EML4-ALK cDNA may become a sensitive diagnostic means for NSCLC cases that are pos. for the fusion gene, and discuss whether suppression of ALK enzymic activity could be an effective treatment strategy against this intractable disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbxSS7U51wKbVg90H21EOLACvtfcHk0ljG5CUFZdweew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisF2gsw%253D%253D&md5=84386550daedbd29b3a34b11a4774684</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2008.00972.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2008.00972.x%26sid%3Dliteratum%253Aachs%26aulast%3DMano%26aufirst%3DH.%26atitle%3DNon-solid%2520Oncogenes%2520in%2520Solid%2520Tumors%253A%2520EML4-ALK%2520Fusion%2520Genes%2520in%2520Lung%2520Cancer%26jtitle%3DCancer%2520Sci.%26date%3D2008%26volume%3D99%26spage%3D2349%26epage%3D2355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Koivunen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span> </span><span class="NLM_article-title"><i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4275</span><span class="NLM_x">–</span> <span class="NLM_lpage">4283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1158%2F1078-0432.CCR-08-0168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=18594010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4275-4283&author=J.+P.+Koivunenauthor=C.+Mermelauthor=K.+Zejnullahuauthor=C.+Murphyauthor=E.+Lifshitsauthor=A.+J.+Holmesauthor=H.+G.+Choiauthor=J.+Kimauthor=D.+Chiangauthor=R.+Thomasauthor=J.+Leeauthor=W.+G.+Richardsauthor=D.+J.+Sugarbakerauthor=C.+Duckoauthor=N.+Lindemanauthor=J.+P.+Marcouxauthor=J.+A.+Engelmanauthor=N.+S.+Grayauthor=C.+Leeauthor=M.+Meyersonauthor=P.+A.+J%C3%A4nne&title=EML4-ALK+Fusion+Gene+and+Efficacy+of+an+ALK+Kinase+Inhibitor+in+Lung+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer</span></div><div class="casAuthors">Koivunen, Jussi P.; Mermel, Craig; Zejnullahu, Kreshnik; Murphy, Carly; Lifshits, Eugene; Holmes, Alison J.; Choi, Hwan Geun; Kim, Jhingook; Chiang, Derek; Thomas, Roman; Lee, Jinseon; Richards, William G.; Sugarbaker, David J.; Ducko, Christopher; Lindeman, Neal; Marcoux, J. Paul; Engelman, Jeffrey A.; Gray, Nathanael S.; Lee, Charles; Meyerson, Matthew; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4275-4283</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The EML4-ALK fusion gene has been detected in ∼7% of Japanese non-small cell lung cancers (NSCLC).  We detd. the frequency of EML4-ALK in Caucasian NSCLC and in NSCLC cell lines.  We also detd. whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK-contg. cell lines in vitro and in vivo.  We screened 305 primary NSCLC [both U.S. (n = 138) and Korean (n = 167) patients] and 83 NSCLC cell lines using reverse transcription-PCR and by exon array analyses.  We evaluated the efficacy of TAE684 against NSCLC cell lines in vitro and in vivo.  We detected four different variants, including two novel variants, of EML4-ALK using reverse transcription-PCR in 8 of 305 tumors (3%) and 3 of 83 (3.6%) NSCLC cell lines.  All EML4-ALK-contg. tumors and cell lines were adenocarcinomas.  EML4-ALK was detected more frequently in NSCLC patients who were never or light (<10 pack-years) cigarette smokers compared with current/former smokers (6% vs. 1%; P = 0.049).  TAE684 inhibited the growth of one of three (H3122) EML4-ALK-contg. cell lines in vitro and in vivo, inhibited Akt phosphorylation, and caused apoptosis.  In another EML4-ALK cell line, DFCI032, TAE684 was ineffective due to coactivation of epidermal growth factor receptor and ERBB2.  The combination of TAE684 and CL-387,785 (epidermal growth factor receptor/ERBB2 kinase inhibitor) inhibited growth and Akt phosphorylation and led to apoptosis in the DFCI032 cell line.  EML4-ALK is found in the minority of NSCLC.  ALK kinase inhibitors alone or in combination may nevertheless be clin. effective treatments for NSCLC patients whose tumors contain EML4-ALK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOXKywqERg6rVg90H21EOLACvtfcHk0ljG5CUFZdweew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D&md5=6e29703c783e6a29cf77e3c4b93fc15f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0168%26sid%3Dliteratum%253Aachs%26aulast%3DKoivunen%26aufirst%3DJ.%2BP.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DDucko%26aufirst%3DC.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DMarcoux%26aufirst%3DJ.%2BP.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DEML4-ALK%2520Fusion%2520Gene%2520and%2520Efficacy%2520of%2520an%2520ALK%2520Kinase%2520Inhibitor%2520in%2520Lung%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D4275%26epage%3D4283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Inamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motoi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mun, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span> </span><span class="NLM_article-title"><i>EML4-ALK</i> Lung Cancers Are Characterized by Rare Other Mutations, A TTF-1 Cell Lineage, An Acinar Histology, and Young Onset</span> <span class="citation_source-journal">Mod. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">515</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1038%2Fmodpathol.2009.2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19234440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslyqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=508-515&author=K.+Inamuraauthor=K.+Takeuchiauthor=Y.+Togashiauthor=S.+Hatanoauthor=H.+Ninomiyaauthor=N.+Motoiauthor=M.+Y.+Munauthor=Y.+Sakaoauthor=S.+Okumuraauthor=K.+Nakagawaauthor=M.+Sodaauthor=Y.+L.+Choiauthor=H.+Manoauthor=Y.+Ishikawa&title=EML4-ALK+Lung+Cancers+Are+Characterized+by+Rare+Other+Mutations%2C+A+TTF-1+Cell+Lineage%2C+An+Acinar+Histology%2C+and+Young+Onset"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset</span></div><div class="casAuthors">Inamura, Kentaro; Takeuchi, Kengo; Togashi, Yuki; Hatano, Satoko; Ninomiya, Hironori; Motoi, Noriko; Mun, Ming-yon; Sakao, Yukinori; Okumura, Sakae; Nakagawa, Ken; Soda, Manabu; Choi, Young Lim; Mano, Hiroyuki; Ishikawa, Yuichi</div><div class="citationInfo"><span class="NLM_cas:title">Modern Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">508-515</span>CODEN:
                <span class="NLM_cas:coden">MODPEO</span>;
        ISSN:<span class="NLM_cas:issn">0893-3952</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A subset of lung cancers harbors a small inversion within chromosome 2p, giving rise to a transforming fusion gene, EML4-ALK (echinoderm microtubule-assocd. protein-like 4 gene and the anaplastic lymphoma kinase gene), which encodes an activated tyrosine kinase.  We have earlier examd. the presence of EML4-ALK by multiplex reverse transcription-polymerase chain reaction in 363 specimens of lung cancer, identifying 11 adenocarcinoma cases featuring the fusion gene.  In this study, we clinicopathol. examd. the characteristics of the EML4-ALK-pos. cases, including the mutation status of EGFR, KRAS, and TP53, and whether they were of thyroid transcription factor-1 (TTF-1) cell lineage or not.  Of 11 patients, 4 (36%) with EML4-ALK-pos. lung adenocarcinomas who were below 50 years of age were affected by these diseases, as compared with 12 of 242 patients (5.0%) with EML4-ALK-neg. lung adenocarcinomas (P=0.00038).  EML4-ALK-pos. lung adenocarcinomas were characterized by less-differentiated grade (P=0.0082) and acinar-predominant structure (P<0.0001) in histol.  Furthermore, the presence of EML4-ALK appears to be mutually exclusive for EGFR and KRAS mutations (P=0.00018), whereas coexisting with TP53 mutations at a low frequency (1/11=9.1%), and correlating with non- or light smoking (P=0.040), in line with the TTF-1 immunoreactivity.  Thus, EML4-ALK-pos. tumors may form a distinct entity among lung adenocarcinomas, characterized by young onset, acinar histol., no or rare mutations in EGFR, KRAS, and TP53, and a TTF-1 cell lineage, all in agreement with the prevalence in non- or light smokers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWmwK64d_PbVg90H21EOLACvtfcHk0ljG5CUFZdweew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslyqtLc%253D&md5=8ed0f0aa75ad9716fe4ae7c0b13754eb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fmodpathol.2009.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmodpathol.2009.2%26sid%3Dliteratum%253Aachs%26aulast%3DInamura%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DTogashi%26aufirst%3DY.%26aulast%3DHatano%26aufirst%3DS.%26aulast%3DNinomiya%26aufirst%3DH.%26aulast%3DMotoi%26aufirst%3DN.%26aulast%3DMun%26aufirst%3DM.%2BY.%26aulast%3DSakao%26aufirst%3DY.%26aulast%3DOkumura%26aufirst%3DS.%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DMano%26aufirst%3DH.%26aulast%3DIshikawa%26aufirst%3DY.%26atitle%3DEML4-ALK%2520Lung%2520Cancers%2520Are%2520Characterized%2520by%2520Rare%2520Other%2520Mutations%252C%2520A%2520TTF-1%2520Cell%2520Lineage%252C%2520An%2520Acinar%2520Histology%252C%2520and%2520Young%2520Onset%26jtitle%3DMod.%2520Pathol.%26date%3D2009%26volume%3D22%26spage%3D508%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Osajima-Hakomori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, R.</span><span> </span><span class="NLM_article-title">Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1016%2FS0002-9440%2810%2962966-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=15972965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2005&pages=213-222&author=Y.+Osajima-Hakomoriauthor=I.+Miyakeauthor=M.+Ohiraauthor=A.+Nakagawaraauthor=A.+Nakagawaauthor=R.+Sakai&title=Biological+Role+of+Anaplastic+Lymphoma+Kinase+in+Neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Biological role of anaplastic lymphoma kinase in neuroblastoma</span></div><div class="casAuthors">Osajima-Hakomori, Yuko; Miyake, Izumi; Ohira, Miki; Nakagawara, Akira; Nakagawa, Atsuko; Sakai, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-222</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a tyrosine kinase receptor originally identified as part of the chimeric nucleophosmin-ALK protein in the t(2;5) chromosomal rearrangement assocd. with anaplastic large cell lymphoma.  We recently demonstrated that the ALK kinase is constitutively activated by gene amplification at the ALK locus in several neuroblastoma cell lines.  Forming a stable complex with hyperphosphorylated ShcC, activated ALK modifies the responsiveness of the mitogen-activated protein kinase pathway to growth factors.  In the present study, the biol. role of activated ALK was examd. by suppressing the expression of ALK kinase in neuroblastoma cell lines using an RNA interference technique.  The suppression of activated ALK in neuroblastoma cells by RNA interference significantly reduced the phosphorylation of ShcC, mitogen-activated protein kinases, and Akt, inducing rapid apoptosis in the cells.  By immunohistochem. anal., the cytoplasmic expression of ALK was detected in most of the samples of neuroblastoma tissues regardless of the stage of the tumor, whereas significant amplification of ALK was obsd. in only 1 of 85 cases of human neuroblastoma samples.  These data demonstrate the limited frequency of ALK activation in the real progression of neuroblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3yzyhgfKX4rVg90H21EOLACvtfcHk0lgaLp1ASSCbng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1eitrc%253D&md5=591aceb254b3e707d315b6309ec5fba0</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962966-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962966-5%26sid%3Dliteratum%253Aachs%26aulast%3DOsajima-Hakomori%26aufirst%3DY.%26aulast%3DMiyake%26aufirst%3DI.%26aulast%3DOhira%26aufirst%3DM.%26aulast%3DNakagawara%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DA.%26aulast%3DSakai%26aufirst%3DR.%26atitle%3DBiological%2520Role%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520in%2520Neuroblastoma%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D167%26spage%3D213%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mossé, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laudenslager, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attiyeh, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laquaglia, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sennett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laureys, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speleman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakonarson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torkamani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schork, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodeur, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonini, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rappaport, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris., J. M.</span><span> </span><span class="NLM_article-title">Identification of <i>ALK</i> as a Major Familial Neuroblastoma Predisposition Gene</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">930</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=930-935&author=Y.+P.+Moss%C3%A9author=M.+Laudenslagerauthor=L.+Longoauthor=K.+A.+Coleauthor=A.+Woodauthor=E.+F.+Attiyehauthor=M.+J.+Laquagliaauthor=R.+Sennettauthor=J.+E.+Lynchauthor=P.+Perriauthor=G.+Laureysauthor=F.+Spelemanauthor=C.+Kimauthor=C.+Houauthor=H.+Hakonarsonauthor=A.+Torkamaniauthor=N.+J.+Schorkauthor=G.+M.+Brodeurauthor=G.+P.+Toniniauthor=E.+Rappaportauthor=M.+Devotoauthor=J.+M.+Maris.&title=Identification+of+ALK+as+a+Major+Familial+Neuroblastoma+Predisposition+Gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoss%25C3%25A9%26aufirst%3DY.%2BP.%26aulast%3DLaudenslager%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DL.%26aulast%3DCole%26aufirst%3DK.%2BA.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DAttiyeh%26aufirst%3DE.%2BF.%26aulast%3DLaquaglia%26aufirst%3DM.%2BJ.%26aulast%3DSennett%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BE.%26aulast%3DPerri%26aufirst%3DP.%26aulast%3DLaureys%26aufirst%3DG.%26aulast%3DSpeleman%26aufirst%3DF.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DHakonarson%26aufirst%3DH.%26aulast%3DTorkamani%26aufirst%3DA.%26aulast%3DSchork%26aufirst%3DN.%2BJ.%26aulast%3DBrodeur%26aufirst%3DG.%2BM.%26aulast%3DTonini%26aufirst%3DG.%2BP.%26aulast%3DRappaport%26aufirst%3DE.%26aulast%3DDevoto%26aufirst%3DM.%26aulast%3DMaris.%26aufirst%3DJ.%2BM.%26atitle%3DIdentification%2520of%2520ALK%2520as%2520a%2520Major%2520Familial%2520Neuroblastoma%2520Predisposition%2520Gene%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D930%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crouthamel, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gontarek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. G.</span><span> </span><span class="NLM_article-title">Myelosuppression and Kinase Selectivity of Multikinase Angiogenesis Inhibitors</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1717</span><span class="NLM_x">–</span> <span class="NLM_lpage">1723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1038%2Fsj.bjc.6605366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=19844230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2hs7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=1717-1723&author=R.+Kumarauthor=M.-C.+Crouthamelauthor=D.+H.+Romingerauthor=R.+R.+Gontarekauthor=P.+J.+Tumminoauthor=R.+A.+Levinauthor=A.+G.+King&title=Myelosuppression+and+Kinase+Selectivity+of+Multikinase+Angiogenesis+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors</span></div><div class="casAuthors">Kumar, R.; Crouthamel, M-C.; Rominger, D. H.; Gontarek, R. R.; Tummino, P. J.; Levin, R. A.; King, A. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1717-1723</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Myelosuppression has been obsd. with several multikinase angiogenesis inhibitors in clin. studies, although the frequency and severity varies among the different agents.  Inhibitors targeting vascular endothelial growth factor receptor (VEGFR) often inhibit other kinases, which may contribute to their adverse-event profiles.  Kinase selectivity of pazopanib, sorafenib, and sunitinib was evaluated in a panel of 242 kinases.  Cellular potency was measured using autophosphorylation assays.  Effect on human bone marrow progenitor growth in the presence of multiple growth factors was evaluated and correlated with the kinase selectivity.  Sunitinib inhibited more kinases than pazopanib and sorafenib, at potencies within 10-fold of VEGFR-2.  All three compds. potently inhibited VEGFR-2, platelet-derived growth factor receptor-β and c-Kit, However, pazopanib was less active against Flt-3 in both kinase and cellular assays.  The inhibitory properties of pazopanib, sorafenib, and sunitinib were dependent on the growth factor used to initiate bone marrow colony formation.  Addn. of stem cell factor and/or Flt-3 ligand with granulocyte-macrophage colony stimulating factor resulted in significant shifts in potency for sorafenib and sunitinib but less so for pazopanib.  Activity against c-kit and Flt-3 by multikinase angiogenesis inhibitors provide a potential explanation for the differences in myelosuppression obsd. with these agents in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyWQK5vGOgLLVg90H21EOLACvtfcHk0lgaLp1ASSCbng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2hs7rL&md5=0ba9f0d114de4ac6b60f772b72719af5</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605366%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DCrouthamel%26aufirst%3DM.-C.%26aulast%3DRominger%26aufirst%3DD.%2BH.%26aulast%3DGontarek%26aufirst%3DR.%2BR.%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DLevin%26aufirst%3DR.%2BA.%26aulast%3DKing%26aufirst%3DA.%2BG.%26atitle%3DMyelosuppression%2520and%2520Kinase%2520Selectivity%2520of%2520Multikinase%2520Angiogenesis%2520Inhibitors%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D1717%26epage%3D1723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Izzedine, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rixe, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billemont, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumelou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deray, G.</span><span> </span><span class="NLM_article-title">Angiogenesis Inhibitor Therapies: Focus on Kidney Toxicity and Hypertension</span> <span class="citation_source-journal">Am. J. Kidney Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm200652u&amp;key=10.1053%2Fj.ajkd.2007.04.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm200652u&amp;key=17660022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=203-218&author=H.+Izzedineauthor=O.+Rixeauthor=B.+Billemontauthor=A.+Baumelouauthor=G.+Deray&title=Angiogenesis+Inhibitor+Therapies%3A+Focus+on+Kidney+Toxicity+and+Hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Angiogenesis inhibitor therapies: focus on kidney toxicity and hypertension</span></div><div class="casAuthors">Izzedine, Hassane; Rixe, Olivier; Billemont, Bertrand; Baumelou, Alain; Deray, Gilbert</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Kidney Diseases</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-218</span>CODEN:
                <span class="NLM_cas:coden">AJKDDP</span>;
        ISSN:<span class="NLM_cas:issn">0272-6386</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Angiogenesis inhibitors that target the epidermal growth factor (EGF) receptor (EGFR) and vascular endothelial growth factor (VEGF) constitute an important addn. to the therapeutic armamentarium for the treatment of patients with metastatic disease.  However, because the same growth factors are expressed in the kidneys, these treatment mols. have renal side effects.  EGFR is expressed mainly in tubules (mainly distal and collecting segments) and mesangial and parietal epithelial cells.  EGF is involved in maintaining tubular integrity and is a potent mitogen for cultured mesangial cells.  Few cases of acute renal failure have been reported related to EGFR inhibitors.  VEGF and VEGF receptors are still highly expressed in the kidney.  VEGF is expressed in podocytes in the glomerulus, and VEGF receptors are present on endothelial, mesangial, and peritubular capillary cells.  Signaling between endothelial cells and podocytes is essential for the proper development and maintenance of the filtration function of the kidney glomerulus.  The most common renal class effects of VEGF antagonists are both manageable; hypertension and proteinuria commonly regressive on drug withdrawal.  There was a dose-dependent increase in risk of proteinuria and hypertension in patients with cancer who received targeted therapies.  Furthermore, few patients with glomerulonephritis or thrombotic microangiopathy secondary to treatment were reported.  Hypertension is believed to be nitric oxide dependent, whereas proteinuria seems to be related to downregulation of podocyte tight junction protein.  This article reviews data relating to hypertension and proteinuria assocd. with the use of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7CD4vNf1df7Vg90H21EOLACvtfcHk0lhqfxVg847irw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSiu7rI&md5=bd6eddeff7e7146eada7c1b4b3fedb5d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1053%2Fj.ajkd.2007.04.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.ajkd.2007.04.025%26sid%3Dliteratum%253Aachs%26aulast%3DIzzedine%26aufirst%3DH.%26aulast%3DRixe%26aufirst%3DO.%26aulast%3DBillemont%26aufirst%3DB.%26aulast%3DBaumelou%26aufirst%3DA.%26aulast%3DDeray%26aufirst%3DG.%26atitle%3DAngiogenesis%2520Inhibitor%2520Therapies%253A%2520Focus%2520on%2520Kidney%2520Toxicity%2520and%2520Hypertension%26jtitle%3DAm.%2520J.%2520Kidney%2520Dis.%26date%3D2007%26volume%3D50%26spage%3D203%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Rodig, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crizotinib, A</span><span> </span><span class="NLM_article-title">Small-Molecule Dual Inhibitor of the c-Met and ALK Receptor Tyrosine Kinases</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1477</span><span class="NLM_x">–</span> <span class="NLM_lpage">1490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=1477-1490&author=S.+J.+Rodigauthor=G.+I.+Shapiroauthor=A+Crizotinib&title=Small-Molecule+Dual+Inhibitor+of+the+c-Met+and+ALK+Receptor+Tyrosine+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodig%26aufirst%3DS.%2BJ.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DCrizotinib%26aufirst%3DA%26atitle%3DSmall-Molecule%2520Dual%2520Inhibitor%2520of%2520the%2520c-Met%2520and%2520ALK%2520Receptor%2520Tyrosine%2520Kinases%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D1477%26epage%3D1490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kinoshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asoh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morikami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span> </span><span class="NLM_article-title">Discovery of Novel Tetracyclic Compounds as Anaplastic Lymphoma Kinase Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3788</span><span class="NLM_x">–</span> <span class="NLM_lpage">3793</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3788-3793&author=K.+Kinoshitaauthor=Y.+Onoauthor=T.+Emuraauthor=K.+Asohauthor=N.+Furuichiauthor=T.+Itoauthor=H.+Kawadaauthor=S.+Tanakaauthor=K.+Morikamiauthor=T.+Tsukaguchiauthor=H.+Sakamotoauthor=T.+Tsukudaauthor=N.+Oikawa&title=Discovery+of+Novel+Tetracyclic+Compounds+as+Anaplastic+Lymphoma+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DEmura%26aufirst%3DT.%26aulast%3DAsoh%26aufirst%3DK.%26aulast%3DFuruichi%26aufirst%3DN.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DKawada%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DOikawa%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520Novel%2520Tetracyclic%2520Compounds%2520as%2520Anaplastic%2520Lymphoma%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3788%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kinoshita, K.; Asoh, K.; Furuichi, N.; Ito, T.; Kawada, H.; Ishii, N.; Sakamoto, H.; Hong, W. S.; Park, M. J.; Ono, Y.; Kato, Y.; Morikami, K.; Emura, T.; Oikawa, N.</span><span> </span><span class="NLM_article-title">Tetracyclic Compound</span>. PCT Int. Appl. WO2010/143664,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+Kinoshita&author=K.+Asoh&author=N.+Furuichi&author=T.+Ito&author=H.+Kawada&author=N.+Ishii&author=H.+Sakamoto&author=W.+S.+Hong&author=M.+J.+Park&author=Y.+Ono&author=Y.+Kato&author=K.+Morikami&author=T.+Emura&author=N.+Oikawa&title=Tetracyclic+Compound"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKinoshita%26aufirst%3DK.%26atitle%3DTetracyclic%2520Compound%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Hart, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C.-Y.</span><span> </span><span class="NLM_article-title">Alkylation of Phenol with a Homoallylic Halide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">3269</span><span class="NLM_x">–</span> <span class="NLM_lpage">3273</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00903a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1963&pages=3269-3273&author=H.+Hartauthor=J.+L.+Corbinauthor=C.+R.+Wagnerauthor=C.-Y.+Wu&title=Alkylation+of+Phenol+with+a+Homoallylic+Halide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fja00903a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00903a047%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DH.%26aulast%3DCorbin%26aufirst%3DJ.%2BL.%26aulast%3DWagner%26aufirst%3DC.%2BR.%26aulast%3DWu%26aufirst%3DC.-Y.%26atitle%3DAlkylation%2520of%2520Phenol%2520with%2520a%2520Homoallylic%2520Halide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1963%26volume%3D85%26spage%3D3269%26epage%3D3273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liao, J. J. L.</span><span> </span><span class="NLM_article-title">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">424</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608107" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200652u&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=409-424&author=J.+J.+L.+Liao&title=Molecular+Recognition+of+Protein+Kinase+Binding+Pockets+for+Design+of+Potent+and+Selective+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Protein Kinase Binding Pockets for Design of Potent and Selective Kinase Inhibitors</span></div><div class="casAuthors">Liao, Jeffrey Jie-Lou</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">409-424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Many kinase inhibitors have failed in preclin. or clin. development because of the lack of such selectivity that induces intolerable side effects, mostly because the catalytic cleft is highly conserved in sequence and conformation.  Systematic anal. of the crystal structures of protein kinases can offer insight into the design of highly selective kinase inhibitors to overcome these effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroDTl2SBUfbbVg90H21EOLACvtfcHk0lhqfxVg847irw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlt1Cmsg%253D%253D&md5=77542d3ba589bd834a0d2b97a24eea05</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm0608107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608107%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DJ.%2BJ.%2BL.%26atitle%3DMolecular%2520Recognition%2520of%2520Protein%2520Kinase%2520Binding%2520Pockets%2520for%2520Design%2520of%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D409%26epage%3D424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">This is the result of our kinase database search. The names and amino acid sequences of ATP binding pocket of the 14 kinases are described in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukami, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oikawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span> </span><span class="NLM_article-title">CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">679</span><span class="NLM_x">–</span> <span class="NLM_lpage">690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=679-690&author=H.+Sakamotoauthor=T.+Tsukaguchiauthor=S.+Hiroshimaauthor=T.+Kodamaauthor=T.+Kobayashiauthor=T.+A.+Fukamiauthor=N.+Oikawaauthor=T.+Tsukudaauthor=N.+Ishiiauthor=Y.+Aoki&title=CH5424802%2C+a+Selective+ALK+Inhibitor+Capable+of+Blocking+the+Resistant+Gatekeeper+Mutant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DTsukaguchi%26aufirst%3DT.%26aulast%3DHiroshima%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DFukami%26aufirst%3DT.%2BA.%26aulast%3DOikawa%26aufirst%3DN.%26aulast%3DTsukuda%26aufirst%3DT.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DY.%26atitle%3DCH5424802%252C%2520a%2520Selective%2520ALK%2520Inhibitor%2520Capable%2520of%2520Blocking%2520the%2520Resistant%2520Gatekeeper%2520Mutant%26jtitle%3DCancer%2520Cell%26date%3D2011%26volume%3D19%26spage%3D679%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">The complex model was prepared using the Molecular Operating Environment software package (MOE 2010.10; Chemical Computing Group Inc., Montreal, Quebec.). The cocrystal structure of human ALK in complex with CH5424802 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AOX">3AOX</a>) was used to construct complex models of compound <b>13a</b>. Compound <b>13a</b> was derived by modifying the original ligand. The missing atoms of human ALK were constructed with reference to other human ALK crystal structures (PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCS">3LCS</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2">2XP2</a>). Solvent molecules within a distance of 5.0 Å around the original ligand were kept. All hydrogen atoms and modified parts of ligand were subjected to energy minimization using MMFF94x force field parameters in combination with GBSA solvent model. The final root-mean-square gradient was set to 0.001.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fischer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacheva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrington, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayhoe, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karpas, A.</span><span> </span><span class="NLM_article-title">A Ki-1 (CD30)-positive Human Cell Line (Karpas 299) Established from a High-Grade Non-Hodgkin’s Lymphoma, Showing a 2;5 Translocation and Rearrangement of the T-Cell Receptor Beta-Chain Gene</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">234</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1988&pages=234-240&author=P.+Fischerauthor=E.+Nachevaauthor=D.+Y.+Masonauthor=P.+D.+Sherringtonauthor=C.+Hoyleauthor=F.+G.+Hayhoeauthor=A.+Karpas&title=A+Ki-1+%28CD30%29-positive+Human+Cell+Line+%28Karpas+299%29+Established+from+a+High-Grade+Non-Hodgkin%E2%80%99s+Lymphoma%2C+Showing+a+2%3B5+Translocation+and+Rearrangement+of+the+T-Cell+Receptor+Beta-Chain+Gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%26aulast%3DNacheva%26aufirst%3DE.%26aulast%3DMason%26aufirst%3DD.%2BY.%26aulast%3DSherrington%26aufirst%3DP.%2BD.%26aulast%3DHoyle%26aufirst%3DC.%26aulast%3DHayhoe%26aufirst%3DF.%2BG.%26aulast%3DKarpas%26aufirst%3DA.%26atitle%3DA%2520Ki-1%2520%2528CD30%2529-positive%2520Human%2520Cell%2520Line%2520%2528Karpas%2520299%2529%2520Established%2520from%2520a%2520High-Grade%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%252C%2520Showing%2520a%25202%253B5%2520Translocation%2520and%2520Rearrangement%2520of%2520the%2520T-Cell%2520Receptor%2520Beta-Chain%2520Gene%26jtitle%3DBlood%26date%3D1988%26volume%3D72%26spage%3D234%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AOX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3AOX','PDB','3AOX'); return false;">PDB: 3AOX</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCS','PDB','3LCS'); return false;">PDB: 3LCS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XP2','PDB','2XP2'); return false;">PDB: 2XP2</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a href="/doi/suppl/10.1021/jm200652u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36100"></div></div></div></div></div><hr /></hr><p class="last">Experimental conditions for enzyme assays. IC<sub>50</sub> values of Table <a class="ref showTableEvent internalNav" href="#tbl1">1</a> in each assay. Amino acid sequences of the 14 kinases having AG at the E<sub>0</sub> region. Pharmacokinetic study of <b>13d</b> in mice. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200652u/suppl_file/jm200652u_si_001.pdf">jm200652u_si_001.pdf (72.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200652u&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm200652u%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-18%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200652u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b144cfd073cd6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
